Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• 'Trifecta' outcomes of robot-assisted partial nephrectomy: a large Japanese multicenter study.1 passage
• 4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study.1 passage
• 4-step, 2-h carboplatin desensitization in Japanese patients with ovarian cancer: a prospective study.1 passage
• A Japanese survey of malignant disease in pregnancy.1 passage
• A Phase III study of radiation therapy (RT) and O⁶-benzylguanine + BCNU versus RT and BCNU alone and methylation status in newly diagnosed glioblastoma and gliosarcoma: Southwest Oncology Group (SWOG) study S0001.1 passage
• A case series on the safety of immunotherapy with reduced blood testing frequency in lung cancer patients.1 passage
• A clinical trial to assess the feasibility and efficacy of nab-paclitaxel plus gemcitabine for elderly patients with unresectable advanced pancreatic cancer.1 passage
• A clinicopathological study of parotid carcinoma: 18-year review of 171 patients at a single institution.1 passage
• A comparison of clinical outcomes between three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancer.1 passage
• A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB-IIA cervical cancer.1 passage
• A critical prognostic analysis of neutrophil-lymphocyte ratio for patients undergoing nephroureterectomy due to upper urinary tract urothelial carcinoma.1 passage
• A double-blind randomized phase II dose-finding study of olanzapine 10 mg or 5 mg for the prophylaxis of emesis induced by highly emetogenic cisplatin-based chemotherapy.1 passage
• A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.1 passage
• A low preoperative albumin-to-globulin ratio is a negative prognostic factor in patients with surgically treated cervical cancer.1 passage
• A mathematical theory of shape and neuro-fuzzy methodology-based diagnostic analysis: a comparative study on early detection and treatment planning of brain cancer.1 passage
• A meta-analysis survey of appropriate bone turnover markers in the detection of bone metastasis in lung cancer.1 passage
• A methylation-specific dot blot assay for improving specificity and sensitivity of methylation-specific PCR on DNA methylation analysis.1 passage
• A multi-institutional observational study on the effects of three-dimensional radiotherapy and weekly 40-mg/m1 passage
• A multicenter phase I/II study of enzalutamide in Japanese patients with castration-resistant prostate cancer.1 passage
• A multicenter phase II trial of preoperative chemoradiotherapy with S-1 plus oxaliplatin and bevacizumab for locally advanced rectal cancer.1 passage
• A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study.1 passage
• A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data.1 passage
• A new prognostic model for chemotherapy-induced febrile neutropenia.1 passage
• A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tables.1 passage
• A novel clinically-oriented classification of fine-needle aspiration cytology for salivary gland tumors: a 20-year retrospective analysis of 1175 patients.1 passage
• A novel nomogram for predicting local recurrence-free survival after surgical resection for retroperitoneal liposarcoma from a Chinese tertiary cancer center.1 passage
• A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer.1 passage
• A phase 2, open-label, multicenter study of ixazomib plus lenalidomide and dexamethasone in adult Japanese patients with relapsed and/or refractory multiple myeloma.1 passage
• A phase I and extension study of S-1 and carboplatin for previously untreated patients aged 75 years or more with advanced non-small cell lung cancer -TCOG 1101.1 passage
• A phase I study of combination therapy with nanoparticle albumin-bound paclitaxel and cyclophosphamide in patients with metastatic or recurrent breast cancer.1 passage
• A phase I study of combined trabectedin and pegylated liposomal doxorubicin therapy for advanced relapsed ovarian cancer.1 passage
• A phase I study of docetaxel/oxaliplatin/S-1 (DOS) combination neoadjuvant chemotherapy for patients with locally advanced adenocarcinoma of the esophagogastric junction.1 passage
• A phase I trial of preoperative S-1 in combination with oxaliplatin and pelvic radiation for lower rectal cancer with T4 and lateral pelvic lymph node metastasis.1 passage
• A phase I, single-center, open-label study of RM-1929 photoimmunotherapy in Japanese patients with recurrent head and neck squamous cell carcinoma.1 passage
• A phase I/II study on stereotactic body radiotherapy with real-time tumor tracking using CyberKnife based on the Monte Carlo algorithm for lung tumors.1 passage
• A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study).1 passage
• A phase II study of 5-fluorouracil/L-leucovorin/oxaliplatin (mFOLFOX6) in Japanese patients with metastatic or unresectable small bowel adenocarcinoma.1 passage
• A phase II study of FOLFIRINOX with primary prophylactic pegfilgrastim for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer.1 passage
• A phase II study of FOLFOXIRI plus bevacizumab as initial chemotherapy for patients with untreated metastatic colorectal cancer: TRICC1414 (BeTRI).1 passage
• A phase II study of adaptive two-step intensity-modulated radiation therapy (IMRT) with chemotherapy for loco-regionally advanced nasopharyngeal cancer (JCOG1015).1 passage
• A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101).1 passage
• A phase II trial of concurrent chemoradiotherapy with weekly paclitaxel and carboplatin in advanced oesophageal carcinoma.1 passage
• A phase II trial of dose-reduced nab-paclitaxel for patients with previously treated, advanced or recurrent gastric cancer (OGSG 1302).1 passage
• A phase III multicenter, randomized, controlled study of combined androgen blockade with versus without zoledronic acid in prostate cancer patients with metastatic bone disease: results of the ZAPCA trial.1 passage
• A population-based study on the associations between chronic periodontitis and the risk of cancer.1 passage
• A population-specific correlation between ADIPOQ rs2241766 and rs 1501299 and colorectal cancer risk: a meta-analysis for debate.1 passage
• A prognostic parameter in advanced non-small cell lung cancer: the ratio of hemoglobin-to-red cell distribution width.1 passage
• A prospective feasibility study applying the ACOSOG Z0011 criteria to Japanese patients with early breast cancer undergoing breast-conserving surgery.1 passage
• A prospective study of XELIRI plus bevacizumab as a first-line therapy in Japanese patients with unresectable or recurrent colorectal cancer (KSCC1101).1 passage
• A prospective study of XELOX plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer (KSCC 0902).1 passage
• A prospective study of palonosetron for prevention of chemotherapy-induced nausea and vomiting in malignant lymphoma patients following highly emetogenic chemotherapy.1 passage
• A prospective study on neurocognitive effects after primary radiotherapy in high-grade glioma patients.1 passage
• A randomized, double-blind, comparison of radium-223 and placebo, in combination with abiraterone acetate and prednisolone, in castration-resistant metastatic prostate cancer: subgroup analysis of Japanese patients in the ERA 223 study.1 passage
• A retrospective analysis of 5-fluorouracil plus cisplatin as first-line chemotherapy in the recent treatment strategy for patients with metastatic or recurrent esophageal squamous cell carcinoma.1 passage
• A retrospective analysis of ramucirumab monotherapy in previously treated Japanese patients with advanced or metastatic gastric adenocarcinoma.1 passage
• A retrospective analysis on the utility and complications of upper arm ports in 433 cases at a single institute.1 passage
• A retrospective assessment of the safety and efficacy of laparoscopic radical hysterectomy in Japan during the early years following its introduction: a Japanese Gynecologic Oncology Group study (JGOG1081S).1 passage
• A risk factor for newly diagnosed secondary cancer in patients with early-stage laryngeal, oropharyngeal, or hypopharyngeal cancer: sub-analysis of a prospective observation study.1 passage
• A single-arm, phase 2 study of steroid-containing mouthwash for the prevention of everolimus-associated stomatitis in multiple tumor types.1 passage
• A single-institute experience of trimodal bladder-preserving therapy for histologic variants of urothelial carcinoma.1 passage
• A statistical study on malignant melanoma over the past 12 years in Fukui University Hospital.1 passage
• A survey on fertility management in young women of reproductive age treated with chemotherapy.1 passage
• A survival analysis using physique-adjusted tumor size of non-small cell lung cancer.1 passage
• A systematic review of publications on charged particle therapy for hepatocellular carcinoma.1 passage
• A triplet combination of FOLFOXIRI plus cetuximab as first-line treatment in RAS wild-type, metastatic colorectal cancer: a dose-escalation phase Ib study.1 passage
• ACO2 and ANPEP as novel prognostic markers for gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas.1 passage
• APC germline variant analysis in the adenomatous polyposis phenotype in Japanese patients.1 passage
• Accuracy of histological grades from intraoperative frozen-section diagnoses of soft-tissue tumors.1 passage
• Accuracy of preoperative diagnosis of lymph node metastasis for thoracic esophageal cancer patients from JCOG9907 trial.1 passage
• Acid-suppressive agents and survival outcomes in patients with cancer: a systematic review and meta-analysis.1 passage
• Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study.1 passage
• Acute toxicity of image-guided hypofractionated proton therapy for localized prostate cancer.1 passage
• Adherent perinephric fat affects perioperative outcomes after partial nephrectomy: a systematic review and meta-analysis.1 passage
• Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy.1 passage
• Adjuvant radiotherapy improves overall survival when added to surgery and chemotherapy for uterine carcinosarcoma: a surveillance, epidemiology, and end results analysis.1 passage
• Adjuvant taxane plus platinum chemotherapy for stage I ovarian clear cell carcinoma with complete surgical staging: are more than three cycles necessary?1 passage
• Adjuvant therapy in renal cell carcinoma: the perspective of urologists.1 passage
• Administration of chemotherapy via the median cubital vein without implantable central venous access ports: port-free chemotherapy for metastatic colorectal cancer patients.1 passage
• Age-based disparities in treatment and outcomes of retroperitoneal rhabdomyosarcoma.1 passage
• Aggressive estrogen-receptor-positive breast cancer arising in patients with elevated body mass index.1 passage
• Aggressive surgery for advanced ovarian cancer decreases the risk of intraperitoneal recurrence.1 passage
• Aging, cancer, and antitumor immunity.1 passage
• Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer.1 passage
• Amyloidosis and the risk of cancer: a nationwide population-based study.1 passage
• An analysis of tumor-related skin temperature differences in malignant soft-tissue tumors.1 passage
• An inflammation index-based prediction of treatment response to neoadjuvant chemoradiotherapy for rectal mucinous adenocarcinoma.1 passage
• An open-label, phase 1 study of androgen receptor antagonist, apalutamide in Japanese patients with metastatic castration-resistant prostate cancer.1 passage
• Analyses of the association between cervical cancer and osteoporosis/osteoporotic fracture: a cross-sectional study using KoGES HEXA data.1 passage
• Analysis and treatment of 45 platinum-allergic gynecologic malignant tumors.1 passage
• Analysis of PALB2 mutations in 155 Japanese patients with breast and/or ovarian cancer.1 passage
• Analysis of major BCR-ABL1 mRNA by digital polymerase chain reaction is useful for prediction of international scale.1 passage
• Analysis of positron emission tomography/computed tomography in patients to differentiate between malignant transformation of endometrioma and endometrioma.1 passage
• Analysis of prognostic factors for patients with bulky squamous cell carcinoma of the uterine cervix who underwent neoadjuvant chemotherapy followed by radical hysterectomy.1 passage
• Analysis of response-related endpoints in trials of first-line medical treatment of metastatic colorectal cancer.1 passage
• Analysis of unexplained carcinoembryonic antigen elevation after curative treatment of locally advanced rectal cancer.1 passage
• Anti-PD-L1/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application.1 passage
• Anxiety and depression associated with tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia.1 passage
• Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.1 passage
• Approving molecularly targeted drugs: different approval processes for cytotoxic agents.1 passage
• Aprepitant for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy.1 passage
• Are all ALK variants created equal? Clinicopathologic features and outcomes: a propensity-matched study.1 passage
• Aspirin use and head and neck cancer survival: an observational study of 11,623 person-years follow-up.1 passage
• Assessment of button-type jejunostomy for nutritional management after esophagectomy in 201 cases.1 passage
• Assessment of surgical outcomes of off-clamp open partial nephrectomy without renorrhaphy for ≥T1b renal tumours.1 passage
• Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma.1 passage
• Association between UGT1A1*28*28 genotype and lung cancer in the Japanese population.1 passage
• Association between chronic kidney disease and mortality in stage IV cancer.1 passage
• Association between nuclear expression of retinoic acid receptor alpha and beta and clinicopathological features and prognosis of advanced non-small cell lung cancer.1 passage
• Association between serum prostate-specific antigen level and diabetes, obesity, hypertension, and the laboratory parameters related to glucose tolerance, hepatic function, and lipid profile: implications for modification of prostate-specific antigen threshold.1 passage
• Association between skeletal muscle loss and the response to nivolumab immunotherapy in advanced gastric cancer patients.1 passage
• Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study).1 passage
• Association of MTHFR gene polymorphisms with pancreatic cancer: meta-analysis of 17 case-control studies.1 passage
• Association of SNPs in the OBFC1 gene and laryngeal carcinoma in Chinese Han male population.1 passage
• Association of TNFα1 passage
• Association of albumin-bilirubin score in patients with colorectal cancer receiving later-line chemotherapy with regorafenib.1 passage
• Association of atopic diseases and parvovirus B19 with acute lymphoblastic leukemia in childhood and adolescence in the northeast of Brazil.1 passage
• Association of decreased mean platelet volume with renal cell carcinoma.1 passage
• Association of employment and company size with lung cancer screening participation among Japanese based on the socioeconomic conditions using the Comprehensive Survey of Living Conditions.1 passage
• Association of the primary tumor's SUVmax with survival after surgery for clinical stage IA esophageal cancer: a single-center retrospective study.1 passage
• Associations between clinical data and computed tomography features in patients with epidermal growth factor receptor mutations in lung adenocarcinoma.1 passage
• Associations between expression levels of nine core nucleotide excision repair genes in lymphocytes and risk of head and neck squamous cell carcinomas in a Chinese population.1 passage
• Atypical and malignant granular cell tumors in Japan: a Japanese Musculoskeletal Oncology Group (JMOG) study.1 passage
• Atypical oncologic failure after laparoscopic and robot-assisted radical cystectomy at a single institution.1 passage
• Axitinib-induced proteinuria and efficacy in patients with metastatic renal cell carcinoma.1 passage
• BRCA1 gene: function and deficiency.1 passage
• Bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomy.1 passage
• Barriers for sperm cryopreservation in advanced germ cell tumor patients: a 20-year experience.1 passage
• Basics of PD-1 in self-tolerance, infection, and cancer immunity.1 passage
• Benefit of intensive chemotherapy for elderly patients aged 80 years or older with metastatic colorectal cancer: a state-wide multicenter cohort study.1 passage
• Bevacizumab combined with platinum-taxane chemotherapy as first-line treatment for advanced ovarian cancer: a prospective observational study of safety and efficacy in Japanese patients (JGOG3022 trial).1 passage
• Bevacizumab-associated events in Japanese women with cervical cancer: a multi-institutional survey of Obstetrical Gynecological Society of Kinki district, Japan.1 passage
• Biological imaging in clinical oncology: radiation therapy based on functional imaging.1 passage
• Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.1 passage
• Biomarkers for precision medicine in bladder cancer.1 passage
• Biomarkers to predict prognosis and response to checkpoint inhibitors.1 passage
• Biphasic decline in renal function after radical cystectomy with urinary diversion.1 passage
• Biphasic malignant tumours of the abdominal cavity.1 passage
• Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety.1 passage
• Blood platelet volume predicts treatment-specific outcomes of metastatic castration-resistant prostate cancer.1 passage
• Body composition as a predictor of toxicity after treatment with eribulin for advanced soft tissue sarcoma.1 passage
• Boron neutron capture therapy (BNCT): a unique role in radiotherapy with a view to entering the accelerator-based BNCT era.1 passage
• Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12).1 passage
• Brachytherapy in the treatment of breast cancer.1 passage
• Breakthrough chemotherapy-induced nausea and vomiting: report of a nationwide survey by the CINV Study Group of Japan.1 passage
• Burden of cardiovascular disease in Japanese cancer patients and survivors: a single cancer-center study in Niigata City.1 passage
• C-reactive protein and the neutrophil-to-lymphocyte ratio are prognostic biomarkers in metastatic renal cell carcinoma patients treated with nivolumab.1 passage
• CAPP-seq analysis of circulating tumor DNA from patients with EGFR T790M-positive lung cancer after osimertinib.1 passage
• CDC20 and its downstream genes: potential prognosis factors of osteosarcoma.1 passage
• COVID-19 infection in pediatric patients treated for cancer.1 passage
• CT and clinical characteristics that predict risk of EGFR mutation in non-small cell lung cancer: a systematic review and meta-analysis.1 passage
• CT-guided percutaneous radiofrequency ablation for lung metastases from colorectal cancer.1 passage
• CXCR4 promotes GSK3β expression in pancreatic cancer cells via the Akt pathway.1 passage
• Calpain suppresses cell growth and invasion of glioblastoma multiforme by producing the cleavage of filamin A.1 passage
• Can serial evaluation of serum SCC-Ag-level predict tumor recurrence and patient survival in squamous-cell carcinoma of uterine cervix treated with definitive chemoradiotherapy? A multi-institutional analysis.1 passage
• Cancer in adolescents and young adults in Japan: epidemiology and cancer strategy.1 passage
• Cancer registries in Japan: National Clinical Database and site-specific cancer registries.1 passage
• Carbon-ion radiotherapy for lymph node oligo-recurrence: a multi-institutional study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS).1 passage
• Carboplatin-based combination chemotherapy for elderly patients with advanced bladder cancer.1 passage
• Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment.1 passage
• Cardiac output response to exercise in patients before allogenic hematopoietic stem cell transplantation.1 passage
• Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration.1 passage
• Cell-type-specific sensitivity of bortezomib in the methotrexate-resistant primary central nervous system lymphoma cells.1 passage
• Cellular immunotherapy plus chemotherapy ameliorates survival in gastric cancer patients: a meta-analysis.1 passage
• Central statistical monitoring of investigator-led clinical trials in oncology.1 passage
• Change in carbohydrate antigen 19-9 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapy.1 passage
• Changes in programmed death ligand 1 expression in non-small cell lung cancer patients who received anticancer treatments.1 passage
• Changes of cancer diagnosis disclosure to children in Japan in the last 20 years.1 passage
• Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA.1 passage
• Characteristic findings of high-grade cervical intraepithelial neoplasia or more on magnifying endoscopy with narrow band imaging.1 passage
• Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo, Japan.1 passage
• Characteristics and outcomes of non-Hodgkin's lymphoma patients with leptomeningeal metastases.1 passage
• Characteristics of MUTYH variants in Japanese colorectal polyposis patients.1 passage
• Characteristics of neoplastic cardiac tamponade and prognosis after pericardiocentesis: a single-center study of 113 consecutive cancer patients.1 passage
• Characterization of mild and severe post-radical nephrectomy renal functional deterioration utilizing histopathological evaluation of non-neoplastic nephrectomized renal parenchyma.1 passage
• Chemoradiotherapy for T4 and/or M1 lymph node esophageal cancer: experience since 2000 at a high-volume center in Japan.1 passage
• Chemoradiotherapy for high-risk stage II laryngeal cancer.1 passage
• Chemotherapy for patients with unresectable or metastatic small bowel adenocarcinoma: a systematic review.1 passage
• Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab approval: a multicenter retrospective analysis.1 passage
• Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse.1 passage
• Circulating microRNAs and extracellular vesicles as potential cancer biomarkers: a systematic review.1 passage
• Circulating tumor cells: clinical validity and utility.1 passage
• Clinical Practice Guidelines for Fertility Preservation in Pediatric, Adolescent, and Young Adults with Cancer.1 passage
• Clinical analysis of febrile neutropenia in urological anticancer chemotherapy: retrospective single center study.1 passage
• Clinical and oncologic outcomes of laparoscopic versus open surgery in elderly patients with colorectal cancer: a retrospective multicenter study.1 passage
• Clinical and pathological outcomes of risk-reducing salpingo-oophorectomy for Japanese women with hereditary breast and ovarian cancer.1 passage
• Clinical background and outcomes of risk-reducing salpingo-oophorectomy for hereditary breast and ovarian cancers in Japan.1 passage
• Clinical benefit of sequential use of endocrine therapies for metastatic breast cancer.1 passage
• Clinical characteristics and outcome of pneumothorax after stereotactic body radiotherapy for lung tumors.1 passage
• Clinical characteristics and predictors of permanent stoma in rectal cancer patients underwent anterior resections: the value of preoperative prognostic nutritional index.1 passage
• Clinical characteristics and surgical outcomes of retroperitoneal tumors: a comprehensive data collection from multiple departments.1 passage
• Clinical effect of multileaf collimator width on the incidence of late rectal bleeding after high-dose intensity-modulated radiotherapy for localized prostate carcinoma.1 passage
• Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit Study.1 passage
• Clinical evaluation of two consecutive UroVysion fluorescence in situ hybridization tests to detect intravesical recurrence of bladder cancer: a prospective blinded comparative study in Japan.1 passage
• Clinical experience of convection-enhanced delivery (CED) of carboplatin and sodium valproate into the pons for the treatment of diffuse intrinsic pontine glioma (DIPG) in children and young adults after radiotherapy.1 passage
• Clinical factors associated with the therapeutic outcome of chemotherapy in very elderly cancer patients.1 passage
• Clinical features and risk factors of panitumumab-induced interstitial lung disease: a postmarketing all-case surveillance study.1 passage
• Clinical features and treatment outcome of desmoid-type fibromatosis: based on a bone and soft tissue tumor registry in Japan.1 passage
• Clinical features and treatment strategy for HPV-related oropharyngeal cancer.1 passage
• Clinical features of long-term survivors of recurrent epithelial ovarian cancer.1 passage
• Clinical impact of periodontal disease on postoperative complications in gastrointestinal cancer patients.1 passage
• Clinical impact of primary tumour1 passage
• Clinical impact of revisions to the WHO classification of diffuse gliomas and associated future problems.1 passage
• Clinical impact of segmental renal vein invasion on recurrence in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy.1 passage
• Clinical impact of weekly paclitaxel plus cetuximab is comparable to the EXTREME regimen for recurrent/metastatic head and neck squamous cell carcinoma.1 passage
• Clinical implications of a prostate-specific antigen bounce after radiation therapy for prostate cancer.1 passage
• Clinical indicators for predicting prognosis after radium-223 administration in castration-resistant prostate cancer with bone metastases.1 passage
• Clinical management and outcomes associated with etoposide, doxorubicin, and cisplatin plus mitotane treatment in metastatic adrenocortical carcinoma: a single institute experience.1 passage
• Clinical outcome of urachal cancer in Japanese patients.1 passage
• Clinical outcomes and predictive value of programmed cell death-ligand 1 expression in response to anti-programmed cell death 1/ligand 1 antibodies in non-small cell lung cancer patients with performance status 2 or greater.1 passage
• Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan.1 passage
• Clinical outcomes of IMRT planned with or without PET/CT simulation for patients with pharyngeal cancers.1 passage
• Clinical outcomes of abnormal cervical cytology and human papillomavirus-related lesions in patients with organ transplantation: 11-year experience at a single institution.1 passage
• Clinical outcomes of brain metastases from hepatocellular carcinoma: a multicenter retrospective study and a literature review.1 passage
• Clinical outcomes of patients with epithelioid sarcomas: impact and management of nodal metastasis.1 passage
• Clinical outcomes of radiotherapy for esophageal cancer between 2004 and 2008: the second survey of the Japanese Radiation Oncology Study Group (JROSG).1 passage
• Clinical outcomes of repeat partial nephrectomy compared to initial partial nephrectomy of a solitary kidney.1 passage
• Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study.1 passage
• Clinical outcomes of second-line treatment following prior targeted therapy in patients with metastatic renal cell carcinoma: a comparison of axitinib and nivolumab.1 passage
• Clinical outcomes of stage IV colorectal cancer after R0 resection: a multi-institutional retrospective analysis.1 passage
• Clinical outcomes of weekly cisplatin chemoradiotherapy for patients with pyriform sinus cancer.1 passage
• Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1).1 passage
• Clinical practice guideline for the treatment of malignant ascites: section summary in Clinical Practice Guideline for peritoneal dissemination (2021).1 passage
• Clinical response to induction chemotherapy predicts improved survival outcome in urothelial carcinoma with clinical lymph nodal metastasis treated by consolidative surgery.1 passage
• Clinical results of carbon-ion radiotherapy with separation surgery for primary spine/paraspinal sarcomas.1 passage
• Clinical results of definitive-dose (50 Gy/25 fractions) preoperative chemoradiotherapy for unresectable esophageal cancer.1 passage
• Clinical significance of hypoxia-inducible factor 1 and VEGF-A in osteosarcoma.1 passage
• Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients.1 passage
• Clinical significance of prognostic nutritional index (PNI) in malignant melanoma.1 passage
• Clinical significance of the pattern-based classification in endocervical adenocarcinoma, usual and variants.1 passage
• Clinical significance of thermal detection of soft-tissue tumors.1 passage
• Clinical target sequencing for precision medicine of breast cancer.1 passage
• Clinical trials of antiangiogenic therapy for hepatocellular carcinoma.1 passage
• Clinical usefulness of cell-free and concentrated ascites reinfusion therapy (CART) in combination with chemotherapy for malignant ascites: a post-marketing surveillance study.1 passage
• Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19).1 passage
• Clinico-pathological characteristics of patients with stage IB1-IB2 (FIGO 2018) uterine cervical cancer: a nationwide study in Japan.1 passage
• Clinicopathologic and survival analysis of patients with adenoid cystic carcinoma of vulva: single-institution experience.1 passage
• Clinicopathologic characteristics of malignant non-hematopoietic tumors first presented as an axillary mass with emphasis on occult breast carcinoma.1 passage
• Clinicopathological characteristics and prognosis analysis of ovarian metastases in colorectal cancer: a single-center experience.1 passage
• Clinicopathological features of esophageal schwannomas in mainland China: systematic review of the literature.1 passage
• Clinicopathological features of radiological early malignant pleural mesothelioma with no apparent tumor or pleural thickening.1 passage
• Clinicopathological features of sporadic MSI colorectal cancer and Lynch syndrome: a single-center retrospective cohort study.1 passage
• Clinicopathological significance of androgen receptor, HER2, Ki-67 and EGFR expressions in salivary duct carcinoma.1 passage
• Coadministration of cytotoxic chemotherapeutic agents with irinotecan is a risk factor for irinotecan-induced cholinergic syndrome in Japanese patients with cancer.1 passage
• Colorectal cancer in young patients: is it a distinct clinical entity?1 passage
• Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer.1 passage
• Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy in the SENRI trial: analysis of risk factors for vomiting and nausea.1 passage
• Combination chemotherapy of low-dose 5-fluorouracil and cisplatin for advanced extramammary Paget's disease.1 passage
• Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma.1 passage
• Combination of TAS-102 and bevacizumab as third-line treatment for metastatic colorectal cancer: TAS-CC3 study.1 passage
• Combination of molecular-targeted drugs with endocrine therapy for hormone-resistant breast cancer.1 passage
• Combination therapy with PD-1 or PD-L1 inhibitors for cancer.1 passage
• Combined antitumor effect of γ-secretase inhibitor and ABT-737 in Notch-expressing non-small cell lung cancer.1 passage
• Combined application of diclofenac and celecoxib with an opioid yields superior efficacy in metastatic bone cancer pain: a randomized controlled trial.1 passage
• Combined detection of Twist1, Snail1 and squamous cell carcinoma antigen for the prognostic evaluation of invasion and metastasis in cervical squamous cell carcinoma.1 passage
• Comparable efficacy and safety between second-line and later-line nivolumab therapy for metastatic renal cell carcinoma.1 passage
• Comparative assessment of prognostic outcomes between first-generation antiandrogens and novel androgen-receptor-axis-targeted agents in patients with non-metastatic castration-resistant prostate cancer.1 passage
• Comparison between 1973 and 2004/2016 World Health Organization grading in upper tract urothelial carcinoma treated with radical nephroureterectomy.1 passage
• Comparison between chemoselection and definitive radiotherapy in patients with cervical esophageal squamous cell carcinoma.1 passage
• Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis.1 passage
• Comparison of 2- and 4-week S-1 administration as adjuvant chemotherapy for advanced gastric cancer.1 passage
• Comparison of S-1-cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials.1 passage
• Comparison of clinical and functional outcome between surgical treatment and carbon ion radiotherapy for pelvic chondrosarcoma.1 passage
• Comparison of clinical outcomes between androgen deprivation therapy with up-front abiraterone and bicalutamide for Japanese patients with LATITUDE high-risk prostate cancer in a real-world retrospective analysis.1 passage
• Comparison of clinical utility between neutrophil count and neutrophil-lymphocyte ratio in patients with ovarian cancer: a single institutional experience and a literature review.1 passage
• Comparison of computed tomography imaging analyses for evaluation after chemotherapy in patients with colorectal cancer: a retrospective pooled analysis of six phase II clinical trials.1 passage
• Comparison of diameter-axial-polar nephrometry and RENAL nephrometry score for treatment decision-making in patients with small renal mass.1 passage
• Comparison of efficacy and toxicity of second-line combination chemotherapy regimens in patients with advanced urothelial carcinoma.1 passage
• Comparison of efficacy outcomes of anticancer drugs between Japanese patients and the overall population.1 passage
• Comparison of intracorporeal versus extracorporeal urinary diversion after robot-assisted radical cystectomy at a medium-sized facility.1 passage
• Comparison of involved field radiotherapy and elective nodal irradiation in combination with concurrent chemotherapy for T1bN0M0 esophageal cancer.1 passage
• Comparison of long-term oncologic outcomes between metastatic ovarian carcinoma originating from gastrointestinal organs and advanced mucinous ovarian carcinoma.1 passage
• Comparison of model fit and discriminatory ability of the 8th edition of the tumor-node-metastasis classification and the 9th edition of the Japanese classification to identify stage III colorectal cancer.1 passage
• Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study.1 passage
• Comparison of plasma amino acid profile-based index and CA125 in the diagnosis of epithelial ovarian cancers and borderline malignant tumors.1 passage
• Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population.1 passage
• Comparison of prognostic impact between positive intraoperative peritoneal and lavage cytologies in colorectal cancer.1 passage
• Comparison of survival outcomes of abdominal radical hysterectomy and radiochemotherapy IIA2 (FIGO2018) cervical cancer: a retrospective study from a large database of 63,926 cases of cervical cancer in China.1 passage
• Comparison of systemic inflammatory and nutritional scores in colorectal cancer patients who underwent potentially curative resection.1 passage
• Comparison of the International Workshop Criteria and the Response Evaluation Criteria in Solid Tumors for indolent B-cell lymphoma.1 passage
• Comparison of the University of Pittsburgh staging system and the eighth edition of the American Joint Committee on Cancer TNM classification for the prognostic evaluation of external auditory canal cancer.1 passage
• Comparison of the diagnostic efficacy and perioperative outcomes of limited versus extended pelvic lymphadenectomy during robot-assisted radical prostatectomy: a multi-institutional retrospective study in Japan.1 passage
• Comparison of therapeutic results from radiofrequency ablation and stereotactic body radiotherapy in solitary lung tumors measuring 5 cm or smaller.1 passage
• Comparison of three different chemotherapy regimens for concomitant chemoradiotherapy in locally advanced non-small cell lung cancer.1 passage
• Comparison of treatment outcomes of pelvis external radiotherapy with and without vaginal brachytherapy for cervical cancer patients with positive or close vaginal resected margins.1 passage
• Complications within 90 days after radical cystectomy for bladder cancer: results of a multicenter prospective study in Japan.1 passage
• Comprehensive analysis of genomic alterations of Chinese hilar cholangiocarcinoma patients.1 passage
• Computed tomography findings for predicting the future occurrence of pancreatic cancer: value of pancreatic volumetry.1 passage
• Computed tomography-derived biomarker for predicting the treatment response to neoadjuvant chemoradiotherapy of rectal cancer.1 passage
• Concordance of clinical diagnosis of T classification among physicians for locally advanced unresectable thoracic esophageal cancer.1 passage
• Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.1 passage
• Considering bone health in the treatment of prostate cancer bone metastasis based on the results of the ERA-223 trial.1 passage
• Construction and validation of a novel prognostic nomogram for patients with sarcomatoid renal cell carcinoma: a SEER-based study.1 passage
• Continuing dilemmas in the management of lymphoma during pregnancy: review of a 10-point case-based questionnaire.1 passage
• Contrast nephropathy in cancer patients receiving anti-VEGF therapy: a prospective study.1 passage
• Contribution of chemotherapy to improved prognosis in stage 4 gastric cancer: trend analysis of a regional population-based cancer registry in Japan.1 passage
• Contributions of HOTAIR polymorphisms to the susceptibility of cancer.1 passage
• Control of chemotherapy-induced nausea in patients receiving outpatient cancer chemotherapy.1 passage
• Control of intracranial disease is associated with improved survival in patients with brain metastasis from hepatocellular carcinoma.1 passage
• Correction to: Fertility in testicular cancer patients: a single‑centre study in Turkey.1 passage
• Correction to: Impact of oral voriconazole during chemotherapy for acute myeloid leukemia and myelodysplastic syndrome: a Japanese nationwide retrospective cohort study.1 passage
• Correction to: Practical guidance for the evaluation of disease progression and the decision to change treatment in patients with advanced gastric cancer receiving chemotherapy.1 passage
• Correction to: Recent advances of the regulation roles of MicroRNA in glioblastoma.1 passage
• Correction to: Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).1 passage
• Correlation between oncological family history and clinical outcome in a large monocentric cohort of pediatric patients with rhabdomyosarcoma.1 passage
• Correlations between CYP3A4 polymorphism and susceptibility to breast cancer in Chinese Han population.1 passage
• Corticosteroid switch after progression on abiraterone acetate plus prednisone.1 passage
• Cost-effectiveness of self-expandable metallic stents as bridge to surgery for obstructive colorectal cancer.1 passage
• CpG island methylator phenotype is associated with the efficacy of sequential oxaliplatin- and irinotecan-based chemotherapy and EGFR-related gene mutation in Japanese patients with metastatic colorectal cancer.1 passage
• Critical appraisal of epigenetic regulation of galectins in cancer.1 passage
• Cryoablation, high-intensity focused ultrasound, irreversible electroporation, and vascular-targeted photodynamic therapy for prostate cancer: a systemic review and meta-analysis.1 passage
• Cryosurgery for primary breast cancers, its biological impact, and clinical outcomes.1 passage
• Current Status of Uterine Leiomyosarcoma in the Tohoku Region: Results of the Tohoku Translational Center Development Network Survey.1 passage
• Current clinical topics of Lynch syndrome.1 passage
• Current issues and perspectives in PD-1 blockade cancer immunotherapy.1 passage
• Current situation of cancer among adolescents and young adults in Japan.1 passage
• Current situation regarding central venous port implantation procedures and complications: a questionnaire-based survey of 11,693 implantations in Japan.1 passage
• Current state of fertility preservation for adolescent and young adult patients with gynecological cancer.1 passage
• Current status and future prospective of focal therapy for localized prostate cancer: development of multiparametric MRI, MRI-TRUS fusion image-guided biopsy, and treatment modalities.1 passage
• Current status of local treatment for early rectal cancer in Japan: a questionnaire survey by the 81st Congress of the Japanese Society for Cancer of the Colon and Rectum (JSCCR) in 2014.1 passage
• Current status of projects for developing cancer-related clinical practice guidelines in Japan and recommendations for the future.1 passage
• Current status of site-specific cancer registry system for the clinical researches: aiming for future contribution by the assessment of present medical care.1 passage
• Current status of superficial pharyngeal squamous cell carcinoma in Japan.1 passage
• Current status of systemic chemotherapy for octogenarians with advanced urothelial cancer in Japan: a Japanese multi-institutional study (CURE study).1 passage
• Current therapeutic strategies for multiple myeloma.1 passage
• Current trend in treatment of glioblastoma in Japan: a national survey using the diagnostic procedure combination database (J-ASPECT study-glioblastoma).1 passage
• Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia.1 passage
• Cytoreductive surgery and HIPEC in treatment of colorectal peritoneal carcinomatosis: experiment or standard care? A survey among oncologic surgeons and medical oncologists.1 passage
• D-dimer predicts postoperative recurrence and prognosis in patients with liver metastasis of colorectal cancer.1 passage
• Daratumumab therapy for relapsed or refractory multiple myeloma: a single-center retrospective study.1 passage
• Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transcripts by imatinib therapy.1 passage
• Data-driven risk identification in phase III clinical trials using central statistical monitoring.1 passage
• Dawn of precision medicine on gastric cancer.1 passage
• Decreased acute toxicities of intensity-modulated radiation therapy for localized prostate cancer with prostate-based versus bone-based image guidance.1 passage
• Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study.1 passage
• Definitive chemoradiotherapy for anal canal cancer: single-center experience.1 passage
• Definitive radiotherapy consisting of whole pelvic radiotherapy with no central shielding and CT-based intracavitary brachytherapy for cervical cancer: feasibility, toxicity, and oncologic outcomes in Japanese patients.1 passage
• Delayed diagnosis and treatment of children with cancer during the COVID-19 pandemic.1 passage
• Detectability of prostate cancer in different parts of the gland with 3-Tesla multiparametric magnetic resonance imaging: correlation with whole-mount histopathology.1 passage
• Detection of bacteria in blood circulation in patients receiving cancer chemotherapy.1 passage
• Detection of circulating tumor cell-specific markers in breast cancer patients using the quantitative RT-PCR assay.1 passage
• Detection of programmed cell death-ligand 1 using 22C3 antibody in patients with unresectable stage III non-small cell lung cancer receiving chemoradiotherapy.1 passage
• Determination of risk factors for progression in patients with viable tumor at post-chemotherapy lymph node dissection due to disseminated non-seminomatous germ-cell tumors.1 passage
• Development and external validation of a nomogram for predicting the effect of tumor size on cancer-specific survival of resected gallbladder cancer: a population-based study.1 passage
• Development and external validation of a nomogram to predict high-grade papillary bladder cancer before first-time transurethral resection of the bladder tumor.1 passage
• Development and validation of a nomogram containing the prognostic determinants of chondrosarcoma based on the Surveillance, Epidemiology, and End Results database.1 passage
• Development of a novel apoptosis-based tumor regression grade to assess the efficacy of preoperative chemoradiotherapy for rectal cancer: a retrospective single-center study.1 passage
• Development of hypertension within 2 weeks of initiation of sorafenib for advanced hepatocellular carcinoma is a predictor of efficacy.1 passage
• Diagnostic accuracies of intraoperative frozen section and permanent section examinations for histological grades during open biopsy of bone tumors.1 passage
• Diagnostic accuracy of computed tomography imaging for the detection of differences between peripheral small cell lung cancer and peripheral non-small cell lung cancer.1 passage
• Diagnostic accuracy of magnetic resonance imaging and computed tomography for lateral lymph node metastasis in rectal cancer: a systematic review and meta-analysis.1 passage
• Diagnostic criteria of sentinel lymph node micrometastasis or macrometastasis based on tissue rinse liquid-based cytology in gynecological cancer.1 passage
• Diagnostic value of multimodal ultrasound imaging in differentiating benign and malignant TI-RADS category 4 nodules.1 passage
• Diagnostic value of tumor markers for lung adenocarcinoma-associated malignant pleural effusion: a validation study and meta-analysis.1 passage
• Dietary glucosylceramides suppress tumor growth in a mouse xenograft model of head and neck squamous cell carcinoma by the inhibition of angiogenesis through an increase in ceramide.1 passage
• Differences in adverse event profiles between everolimus and temsirolimus and the risk factors for non-infectious pneumonitis in advanced renal cell carcinoma.1 passage
• Differences in attitude toward adjuvant chemotherapy between colorectal cancer survivors and the medical staff of Japanese hospitals.1 passage
• Differences in histological features and PD-L1 expression between sporadic microsatellite instability and Lynch-syndrome-associated disease in Japanese patients with colorectal cancer.1 passage
• Different clinicopathological features between patients who developed early and late recurrence following surgery for renal cell carcinoma.1 passage
• Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System.1 passage
• Discrimination between breast invasive ductal carcinomas and benign lesions by optimizing quantitative parameters derived from dynamic contrast-enhanced MRI using a semi-automatic method.1 passage
• Disease control and clinicopathological prognostic factors of total pharyngolaryngectomy for hypopharyngeal cancer: a single-center study.1 passage
• Distribution analysis of hydrogel spacer and evaluation of rectal dose reduction in Japanese prostate cancer patients undergoing stereotactic body radiation therapy.1 passage
• Do all patients in the phase I oncology trials need to be hospitalized? Domestic but outstanding issues for globalization of drug development in Japan.1 passage
• Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer?1 passage
• Docetaxel and carboplatin chemotherapy for treating patients with stage IVB or recurrent non-squamous cell carcinoma of the uterine cervix: a phase II study.1 passage
• Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis?1 passage
• Does postoperative prophylactic irradiation of para-aortic lymph nodes reduce the risk of recurrence in uterine cervical cancer with positive pelvic lymph nodes?1 passage
• Does the extension of the type of hysterectomy contribute to the local control of endometrial cancer?1 passage
• Does tumour effraction during robotic partial nephrectomy have any impact on recurrence?1 passage
• Dominant lymph drainage patterns in the occipital and parietal regions: evaluation of lymph nodes in patients with skin cancer of the head.1 passage
• Donor interleukin 6 gene polymorphisms predict the recurrence of hepatocellular carcinoma after liver transplantation.1 passage
• Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study.1 passage
• Down-regulation of miR-200c associates with poor prognosis of oral squamous cell carcinoma.1 passage
• Dynamic prediction of cancer-specific survival for primary hypopharyngeal squamous cell carcinoma.1 passage
• EGF rs4444903 polymorphism is associated with risk of HCV-related cirrhosis and HBV/HCV-related hepatocellular carcinoma.1 passage
• Early intervention using high-precision radiotherapy preserved visual function for five consecutive patients with optic nerve sheath meningioma.1 passage
• Early recurrence after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).1 passage
• Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors.1 passage
• Early stage non-small cell lung cancer patients need brain imaging regardless of symptoms.1 passage
• Early tumor shrinkage after first-line medical treatment of metastatic colorectal cancer: a meta-analysis.1 passage
• Effect of SIB-IMRT-based selective dose escalation of local tumor on the prognosis of patients with esophageal cancer.1 passage
• Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001).1 passage
• Effect of androgen deprivation therapy on arterial stiffness and serum lipid profile changes in patients with prostate cancer: a prospective study of initial 6-month follow-up.1 passage
• Effect of combination of pre- and postoperative pulmonary rehabilitation on onset of postoperative pneumonia: a retrospective cohort study based on data from the diagnosis procedure combination database in Japan.1 passage
• Effect of core needle biopsy number on intraductal carcinoma of the prostate (IDC-P) diagnosis in patients with metastatic hormone-sensitive prostate cancer.1 passage
• Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial.1 passage
• Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients.1 passage
• Effect of everolimus treatment for regrown renal angiomyolipoma associated with tuberous sclerosis complex after transcatheter arterial embolization.1 passage
• Effect of everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex: an evaluation based on tumor density.1 passage
• Effect of general self-efficacy on promoting health-related quality of life during recovery from radical prostatectomy: a 1-year prospective study.1 passage
• Effect of intraoperative radiotherapy in the treatment of retroperitoneal sarcoma.1 passage
• Effect of post-filter anticoagulation on mortality in patients with cancer-associated pulmonary embolism.1 passage
• Effect of postoperative radiotherapy on survival in duodenal adenocarcinoma: a propensity score-adjusted analysis of Surveillance, Epidemiology, and End Results database.1 passage
• Effect of skip lymphovascular invasion on hepatic metastasis in colorectal carcinomas.1 passage
• Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy.1 passage
• Effect of tumor burden and growth rate on treatment outcomes of nivolumab in head and neck cancer.1 passage
• Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccination.1 passage
• Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study.1 passage
• Effectiveness of nivolumab affected by prior cetuximab use and neck dissection in Japanese patients with recurrent or metastatic head and neck cancer: results from a retrospective observational study in a real-world setting.1 passage
• Effectiveness of repeat surgery for recurrence after primary hepatectomy in patients with intrahepatic cholangiocarcinoma.1 passage
• Effects of cell-free and concentrated ascites reinfusion therapy (CART) on symptom relief of malignancy-related ascites.1 passage
• Effects of chemotherapy on patients with recurrent cervical cancer previously treated with concurrent chemoradiotherapy: a retrospective multicenter survey in Japan.1 passage
• Effects of neutropenia and histological responses in esophageal squamous cell carcinoma with neo-adjuvant chemotherapy.1 passage
• Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study.1 passage
• Effects of transurethral resection under general anesthesia on tumor recurrence in non-muscle invasive bladder cancer.1 passage
• Efficacy and feasibility of S-1 plus oxaliplatin (C-SOX) for treating patients with stage III colon cancer (KSCC1303): final analysis of 3-year disease-free survival.1 passage
• Efficacy and feasibility of docetaxel, cisplatin, and 5-fluorouracil induction chemotherapy for locally advanced head and neck squamous cell carcinoma classified as clinical nodal stage N2c, N3, or N2b with supraclavicular lymph node metastases.1 passage
• Efficacy and feasibility of induction chemotherapy with paclitaxel, carboplatin and cetuximab for locally advanced unresectable head and neck cancer patients ineligible for combination treatment with docetaxel, cisplatin, and 5-fluorouracil.1 passage
• Efficacy and safety of1 passage
• Efficacy and safety of anlotinib in patients with advanced malignancy: a single-center, single-arm, phase 2 trial.1 passage
• Efficacy and safety of darolutamide in Japanese patients with nonmetastatic castration-resistant prostate cancer: a sub-group analysis of the phase III ARAMIS trial.1 passage
• Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol.1 passage
• Efficacy and safety of low-dose everolimus treatment for renal angiomyolipoma associated with tuberous sclerosis complex.1 passage
• Efficacy and safety of neoadjuvant chemotherapy with concurrent liposomal-encapsulated doxorubicin, paclitaxel and trastuzumab for human epidermal growth factor receptor 2-positive breast cancer in clinical practice.1 passage
• Efficacy and safety of nivolumab combined with brentuximab vedotin after nivolumab monotherapy failure in patients with relapsed and refractory classic Hodgkin lymphoma.1 passage
• Efficacy and safety of nivolumab for renal cell carcinoma in patients over 75 years old from multiple Japanese institutes.1 passage
• Efficacy and safety of nivolumab in Japanese patients with first recurrence of glioblastoma: an open-label, non-comparative study.1 passage
• Efficacy and safety of oxaliplatin-based regimen versus cisplatin-based regimen in the treatment of gastric cancer: a meta-analysis of randomized controlled trials.1 passage
• Efficacy and safety of ramucirumab plus modified FOLFIRI for metastatic colorectal cancer.1 passage
• Efficacy and safety of ramucirumab plus paclitaxel therapy for advanced gastric cancer patients treated previously with docetaxel-containing chemotherapy.1 passage
• Efficacy and safety of sorafenib for treatment of Japanese metastatic renal cell carcinoma patients undergoing hemodialysis.1 passage
• Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined by titration for the treatment of breakthrough pain in Japanese cancer patients: a multicenter, randomized, placebo-controlled, double-blind phase III trial.1 passage
• Efficacy and safety of third-line molecular-targeted therapy in metastatic renal cell carcinoma resistant to first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor and second-line therapy.1 passage
• Efficacy and safety of tisagenlecleucel in Japanese adult patients with relapsed/refractory diffuse large B-cell lymphoma.1 passage
• Efficacy and safety profile of nivolumab for Japanese patients with metastatic renal cell cancer.1 passage
• Efficacy and toxicity of transarterial chemoembolization therapy using cisplatin and gelatin sponge in patients with liver metastases from uveal melanoma in an Asian population.1 passage
• Efficacy of anti-PD-1 therapy for recurrence after chemoradiotherapy in locally advanced NSC LC.1 passage
• Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin.1 passage
• Efficacy of chemotherapy for older patients with gastric cancer: a multicenter retrospective cohort study.1 passage
• Efficacy of daikenchuto, a traditional Japanese Kampo medicine, for postoperative intestinal dysfunction in patients with gastrointestinal cancers: meta-analysis.1 passage
• Efficacy of docetaxel in castration-resistant prostate cancer patients with intraductal carcinoma of the prostate.1 passage
• Efficacy of intraoperative entire-circumferential frozen section analysis of lumpectomy margins during breast-conserving surgery for breast cancer.1 passage
• Efficacy of local salvage therapy for recurrent uterine cervical cancer after definitive radiotherapy.1 passage
• Efficacy of modified FOLFOX6 chemotherapy for patients with unresectable pseudomyxoma peritonei.1 passage
• Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis.1 passage
• Efficacy of neoadjuvant chemotherapy in patients with high-risk resectable colorectal liver metastases.1 passage
• Efficacy of neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 for resectable locally advanced gastric cancer.1 passage
• Efficacy of palliative radiotherapy and chemo-radiotherapy for unresectable gastric cancer demonstrating bleeding and obstruction.1 passage
• Efficacy of palonosetron and 1-day dexamethasone in moderately emetogenic chemotherapy compared with fosaprepitant, granisetron, and dexamethasone: a prospective randomized crossover study.1 passage
• Efficacy of weekly administration of paclitaxel and carboplatin for advanced ovarian cancer patients with poor performance status.1 passage
• Elevated expression of the RNA-binding motif protein 43 predicts poor prognosis in esophageal squamous cell carcinoma.1 passage
• Elevated preoperative neutrophil-to-lymphocytes ratio predicts poor prognosis after esophagectomy in T1 esophageal cancer.1 passage
• Elevated serum soluble interleukin-2 receptor levels increase malignancy-related risk in patients on chronic hemodialysis.1 passage
• Emerging RAS, BRAF, and EGFR mutations in cell-free DNA of metastatic colorectal patients are associated with both primary and secondary resistance to first-line anti-EGFR therapy.1 passage
• Employment status and termination among survivors of pediatric brain tumors: a cross-sectional survey.1 passage
• Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts.1 passage
• Endoscopic sequestrectomy for skull base osteoradionecrosis in nasopharyngeal carcinoma patients: a 10‑year experience.1 passage
• Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: a retrospective study.1 passage
• Enzalutamide versus flutamide for castration-resistant prostate cancer after combined androgen blockade therapy with bicalutamide: the OCUU-CRPC study.1 passage
• Epidemiology and prognosis of lymphoepithelioma-like carcinoma: a comprehensive analysis of surveillance, epidemiology, and end results (SEER) database.1 passage
• Epidemiology and survival outcomes of primary gastrointestinal melanoma: a SEER-based population study.1 passage
• Esophageal squamous cell neoplasia is an independent negative prognostic factor for head and neck cancer patients.1 passage
• Esophageal stenosis and the Glasgow Prognostic Score as independent factors of poor prognosis for patients with locally advanced unresectable esophageal cancer treated with chemoradiotherapy (exploratory analysis of JCOG0303).1 passage
• Esophagectomy for the patients with squamous cell carcinoma of the esophagus after allogeneic hematopoietic stem cell transplantation.1 passage
• Establishment and validation of a novel survival prediction scoring algorithm for patients with non-small-cell lung cancer spinal metastasis.1 passage
• Establishment of nedaplatin safety dose formula based on renal function for combination chemotherapy with nedaplatin and 5-fluorouracil in patients with esophageal cancer.1 passage
• Estimated tumor blood flow as a predictive imaging indicator of therapeutic response in pancreatic ductal adenocarcinoma: use of three-phase contrast-enhanced computed tomography.1 passage
• Estimation of Physiologic Ability and Surgical Stress (E-PASS) versus modified E-PASS for prediction of postoperative complications in elderly patients who undergo gastrectomy for gastric cancer.1 passage
• Estramustine phosphate sodium in heavily pretreated patients with metastatic breast cancer: a retrospective consecutive case series.1 passage
• Evaluation of COVID 19 infection in 279 cancer patients treated during a 90-day period in 2020 pandemic.1 passage
• Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study).1 passage
• Evaluation of a routine second curettage for hydatidiform mole: a cohort study.1 passage
• Evaluation of adjuvant chemotherapy after abdominal trachelectomy for cervical cancer: a single-institution experience.1 passage
• Evaluation of postoperative chemotherapy in patients with uterine carcinosarcoma: a retrospective survey of the Tohoku Gynecologic Cancer Unit.1 passage
• Evaluation of the clinical value of carbon nanoparticles as lymph node tracer in differentiated thyroid carcinoma requiring reoperation.1 passage
• Evaluation of the concordance in HPV type between self- and physician-collected samples using a brush-based device and a PCR-based HPV DNA test in Japanese referred patients with abnormal cytology or HPV infection.1 passage
• Evaluation of the efficacy of palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with gastric cancer treated with S-1 plus cisplatin.1 passage
• Exosomal miR-1246 in serum as a potential biomarker for early diagnosis of gastric cancer.1 passage
• Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations.1 passage
• Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma.1 passage
• Expression and role of V1A subunit of V-ATPases in gastric cancer cells.1 passage
• Expression of PBRM1 as a prognostic predictor in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitor.1 passage
• Expression of a novel endothelial marker, C-type lectin 14A, in epithelial ovarian cancer and its prognostic significance.1 passage
• Expression of costimulatory molecules B7-H1, B7-H4 and Foxp3+ Tregs in gastric cancer and its clinical significance.1 passage
• Expression of p53, p16, cyclin D1, epidermal growth factor receptor and Notch1 in patients with temporal bone squamous cell carcinoma.1 passage
• Extensive analysis of signaling pathway molecules in breast cancer: association with clinicopathological characteristics.1 passage
• Extent of neck dissection for patients with clinical N1 oral cancer.1 passage
• Extent of thyroid resection and thyroid function after postoperative radiotherapy following total laryngectomy or total pharyngo-laryngo-esophagectomy.1 passage
• External validation of a postoperative nomogram for the prediction of disease-specific survival in patients with papillary renal cell carcinoma using a large multicenter database.1 passage
• External validation of existing nomograms predicting lymph node metastases in cystectomized patients.1 passage
• External validation of nomograms for prediction of progression-free survival and liver toxicity in patients with advanced renal cell carcinoma treated with pazopanib.1 passage
• External validation of the "optimal PSA follow-up schedule after radical prostatectomy" in a new cohort.1 passage
• External validation of the Briganti 2019 nomogram to identify candidates for extended pelvic lymph node dissection among patients with high-risk clinically localized prostate cancer.1 passage
• External validation of the systemic immune-inflammation index as a prognostic factor in metastatic renal cell carcinoma and its implementation within the international metastatic renal cell carcinoma database consortium model.1 passage
• FAM83A drives PD-L1 expression via ERK signaling and FAM83A/PD-L1 co-expression correlates with poor prognosis in lung adenocarcinoma.1 passage
• FDG-PET might not contribute to improving survival in patients with locally advanced inoperable esophageal cancer.1 passage
• FDG-PET reflects tumor viability on SUV in colorectal cancer liver metastasis.1 passage
• FLOX (5-fluorouracil + leucovorin + oxaliplatin) chemotherapy for colorectal cancer leads to long-term orofacial neurotoxicity: a STROBE-guided longitudinal prospective study.1 passage
• FOXP3 autoantibody as a potential early prognostic serum biomarker in patients with cervical cancer.1 passage
• Factors affecting R0 resection of colorectal cancer with synchronous peritoneal metastases: a multicenter prospective observational study by the Japanese Society for Cancer of the Colon and Rectum.1 passage
• Factors predicting efficacy and adverse effects of enzalutamide in Japanese patients with castration-resistant prostate cancer: results of retrospective multi-institutional study.1 passage
• Factors related to cervical cancer screening among women of childrearing age: a cross-sectional study of a nationally representative sample in Japan.1 passage
• Failure mode and effects analysis of medication adherence in patients with chronic myeloid leukemia.1 passage
• Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology.1 passage
• Familial cancer of unknown primary.1 passage
• Fatigue associated with newly approved vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: an up-to-date meta-analysis.1 passage
• Favorable outcome of intraoperative radiotherapy to the primary site in patients with metastatic prostate cancer.1 passage
• Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands.1 passage
• Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with concurrent weekly cisplatin chemoradiotherapy for locally advanced head and neck squamous cell carcinoma.1 passage
• Feasibility and safety of dose-dense modified docetaxel-cisplatin or carboplatin and 5-fluorouracil regimen (mTPF) in locally advanced or metastatic head and neck cancers: a retrospective monocentric study.1 passage
• Feasibility evaluation of hypofractionated radiotherapy with concurrent temozolomide in elderly patients with glioblastoma.1 passage
• Feasibility of adjuvant chemotherapy with S-1 plus carboplatin followed by single-agent maintenance therapy with S-1 for completely resected non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 1001.1 passage
• Feasibility of dose-dense epirubicin and cyclophosphamide with subcutaneous pegfilgrastim 3.6 mg support: a single-center prospective study in Japan.1 passage
• Feasibility of initial treatment in elderly patients with ovarian cancer in Japan: a retrospective study.1 passage
• Feasibility of laparoscopic adrenalectomy for metastatic adrenal tumors in selected patients: a retrospective multicenter study of Japanese populations.1 passage
• Feasibility of laparoscopic total proctocolectomy with ileal pouch-anal anastomosis and total colectomy with ileorectal anastomosis for familial adenomatous polyposis: results of a nationwide multicenter study.1 passage
• Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial).1 passage
• Feasibility study of postoperative adjuvant chemotherapy with S-1 in patients with biliary tract cancer.1 passage
• Feasibility study on combination chemotherapy using nogitecan hydrochloride (topotecan) and cisplatin for patients with metastatic, persistent, or recurrent uterine cervical cancer.1 passage
• Fertility in testicular cancer patients: a single-centre study in Turkey.1 passage
• Fertility preservation and fulfillment of parenthood after treatment of hematological malignancies: results from the 'Aftercare in Blood Cancer Survivors' (ABC) study.1 passage
• Fertility preservation for female cancer patients.1 passage
• Fibrates protect against vascular endothelial dysfunction induced by paclitaxel and carboplatin chemotherapy for cancer patients: a pilot study.1 passage
• Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer.1 passage
• Final report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japan.1 passage
• First-line bolus 5-fluorouracil plus leucovorin for peritoneally disseminated gastric cancer with massive ascites or inadequate oral intake.1 passage
• First-line durvalumab plus platinum-etoposide in extensive-stage small-cell lung cancer: CASPIAN Japan subgroup analysis.1 passage
• First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary study.1 passage
• Five-year outcomes following hypofractionated stereotactic radiotherapy delivered in five fractions for acoustic neuromas: the mean cochlear dose may impact hearing preservation.1 passage
• Fluorodeoxyglucose positron emission tomography/computed tomography for diagnosis of upper urinary tract urothelial carcinoma.1 passage
• Focal therapy with high-intensity focused ultrasound for the localized prostate cancer for Asian based on the localization with MRI-TRUS fusion image-guided transperineal biopsy and 12-cores transperineal systematic biopsy: prospective analysis of oncological and functional outcomes.1 passage
• Forkhead box protein O1 (FOXO1) and paired box gene 3 (PAX3) overexpression is associated with poor prognosis in patients with cervical cancer.1 passage
• Fractionated stereotactic radiotherapy for metastatic brain tumors that recurred after gamma knife radiosurgery results in acceptable toxicity and favorable local control.1 passage
• Frailty is associated with poor prognosis after resection for pancreatic cancer.1 passage
• Frequency and predictors of detecting early locoregional recurrence/disease progression of oral squamous cell carcinoma with high-risk factors on imaging tests before postoperative adjuvant radiotherapy.1 passage
• Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutations.1 passage
• Frequency of level II and III axillary nodes metastases in patients with positive sentinel lymph nodes in melanoma: a multi-institutional study in Japan.1 passage
• Future projection of cancer patients with cardiovascular disease in Japan by the year 2039: a pilot study.1 passage
• Gastrectomy for invasive micropapillary carcinoma is associated with poorer disease-free and disease-specific survival.1 passage
• Gastrointestinal lesion in adult-onset Langerhans cell histiocytosis.1 passage
• Gefitinib treatment in patients with postoperative recurrent non-small-cell lung cancer harboring epidermal growth factor receptor gene mutations.1 passage
• Gemcitabine in patients previously treated with platinum-containing chemotherapy for refractory thymic carcinoma: radiographic assessment using the RECIST criteria and the ITMIG recommendations.1 passage
• Gemcitabine monotherapy in patients with heavily treated nasopharyngeal cancer: a case series.1 passage
• Gender differences in colorectal cancer survival in Japan.1 passage
• Gene-expression profiles correlate with the efficacy of anti-EGFR therapy and chemotherapy for colorectal cancer.1 passage
• General rules for clinical and pathological studies on oral cancer (2nd edition): a synopsis.1 passage
• Genetic abnormalities and pathophysiology of MDS.1 passage
• Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome.1 passage
• Genetic association of promoter in GRP78 gene with nasopharyngeal carcinoma in a Chinese population.1 passage
• Genetic mutation analysis of the malignant transformation of sinonasal inverted papilloma by targeted amplicon sequencing.1 passage
• Gestational trophoblastic neoplasia with brain metastasis at initial presentation: a retrospective study.1 passage
• Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia.1 passage
• Goshajinkigan for reducing chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis.1 passage
• Grade group 2 (10% ≥ GP4) patients have very similar malignant potential with grade group 1 patients, given the risk of intraductal carcinoma of the prostate.1 passage
• Growth rate of chemotherapy-naïve lung metastasis from colorectal cancer could be a predictor of early relapse after lung resection.1 passage
• HER2-low breast cancer could be associated with an increased risk of brain metastasis.1 passage
• HOXC9 overexpression is associated with gastric cancer progression and a prognostic marker for poor survival in gastric cancer patients.1 passage
• HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.1 passage
• HPV vaccination in Japan: can educational intervention promote a father's intention to encourage his daughter's vaccination?1 passage
• HPV vaccination in Japan: results of a 3-year follow-up survey of obstetricians and gynecologists regarding their opinions toward the vaccine.1 passage
• Hand-foot syndrome and survival in patients with advanced non-small-cell lung cancer receiving anlotinib: a subgroup analysis of data from the ALTER 0303 study.1 passage
• Health insurance status and survival among patients with head and neck cancer in Japan.1 passage
• Health-related quality of life in Japanese patients with bladder cancer measured by a newly developed Japanese version of the Bladder Cancer Index.1 passage
• Hepatectomy for oligo-recurrence of non-small cell lung cancer in the liver.1 passage
• Hepatic arterial infusion chemotherapy with fine-powder cisplatin and iodized-oil suspension in patients with intermediate-stage and advanced-stage (Barcelona Clinic Liver Cancer stage-B or stage-C) hepatocellular carcinoma: multicenter phase-II clinical study.1 passage
• Hepatitis B virus reactivation during temozolomide administration for malignant glioma.1 passage
• Hereditary pancreatic cancer.1 passage
• Heterogeneous distribution of PD-L1 expression in the IASLC/ATS/ERS classification of lung adenocarcinoma.1 passage
• Hibernation of masses suspected to be remnant tumors after surgical resection of retroperitoneal liposarcoma is related to improved overall survival.1 passage
• High FRMD3 expression is prognostic for worse survival in rectal cancer patients treated with CCRT.1 passage
• High diagnostic efficacy of 5-aminolevulinic acid-induced fluorescent urine cytology for urothelial carcinoma.1 passage
• High expression of GRP78/BiP as a novel predictor of favorable outcomes in patients with advanced thymic carcinoma.1 passage
• High expression of miR-195 is related to favorable prognosis in cytogenetically normal acute myeloid leukemia.1 passage
• High expression of microRNA20b is associated with malignant clinicopathological features and poor prognosis in breast phyllodes tumor.1 passage
• High hepatitis B virus screening rate among patients receiving systemic anticancer treatment in Japan.1 passage
• High incidence of urological complications in men dying from prostate cancer.1 passage
• High platelet × C-reactive protein level multiplier is a negative prognostic marker in rectal cancer treated by neoadjuvant chemoradiotherapy.1 passage
• High-grade complication is associated with poor overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.1 passage
• Histologic grade and peritoneal cytology as prognostic factors in type 1 endometrial cancer.1 passage
• Histologic transformation of non-small-cell lung cancer in brain metastases.1 passage
• Histological transformation after acquired resistance to epidermal growth factor tyrosine kinase inhibitors.1 passage
• History of whole pelvis plus para-aortic radiation is a risk factor associated with febrile neutropenia during chemotherapy for recurrent cervical cancer.1 passage
• How asymptomatic are early cancer patients of five organs based on registry data in Japan.1 passage
• How do Japanese gynecologists view hormone replacement therapy for survivors of endometrial cancer? Japanese Gynecologic Oncology Group (JGOG) survey.1 passage
• How do doctors choose treatment for older gynecological cancer patients? A Japanese Gynecologic Oncology Group survey of gynecologic oncologists.1 passage
• How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer?1 passage
• How to make clinical decisions to avoid unnecessary prostate screening in biopsy-naïve men with PI-RADs v2 score ≤ 3?1 passage
• Hsa_circ_0003195 as a biomarker for diagnosis and prognosis of gastric cancer.1 passage
• Human collagen XV is a prominent histopathological component of sinusoidal capillarization in hepatocellular carcinogenesis.1 passage
• Human cytomegalovirus protein UL136 activates the IL-6/STAT3 signal through MiR-138 and MiR-34c in gastric cancer cells.1 passage
• Human papillomavirus type-specific persistence and reappearance after successful conization in patients with cervical intraepithelial neoplasia.1 passage
• Human papillomavirus vaccination of the daughters of obstetricians and gynecologists in Japan.1 passage
• Hyaluronic acid binding protein 1 overexpression is an indicator for disease-free survival in cervical cancer.1 passage
• Hypersensitivity to chemotherapeutics: a cross sectional study with 35 desensitisations.1 passage
• Hypofractionated chemoradiotherapy with temozolomide as a treatment option for glioblastoma patients with poor prognostic features.1 passage
• Hyponatremia as a powerful prognostic predictor for Japanese patients with clear cell renal cell carcinoma treated with a tyrosine kinase inhibitor.1 passage
• Identification of Lynch syndrome-associated DNA mismatch repair-deficient bladder cancer in a Japanese hospital-based population.1 passage
• Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis.1 passage
• Identification of a predictive factor for distant metastasis in esophageal squamous cell carcinoma after definitive chemoradiotherapy.1 passage
• Identification of adverse events that have a negative impact on quality of life in a clinical trial comparing docetaxel versus S-1 with cisplatin in lung cancer.1 passage
• Identification of curable high-risk prostate cancer using radical prostatectomy alone: who are the good candidates for undergoing radical prostatectomy among patients with high-risk prostate cancer?1 passage
• Imaging strategy for response evaluation to chemoradiotherapy of the nodal disease in patients with head and neck squamous cell carcinoma.1 passage
• Immune check-point in endometrial cancer.1 passage
• Immune checkpoint inhibitor-induced sarcoidosis-like granulomas.1 passage
• Immune-resistant mechanisms in cancer immunotherapy.1 passage
• Impact of Gleason pattern 5 including tertiary pattern 5 on outcomes of salvage treatment for biochemical recurrence in pT2-3N0M0 prostate cancer.1 passage
• Impact of RAS/BRAF mutation status in locally advanced rectal cancer treated with preoperative chemotherapy.1 passage
• Impact of a reduction in follow-up frequency on life expectancy in uterine cervical cancer patients.1 passage
• Impact of a robotic surgical system on treatment choice for men with clinically organ-confined prostate cancer.1 passage
• Impact of age on clinicopathological features and survival of epithelial ovarian neoplasms in reproductive age.1 passage
• Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers.1 passage
• Impact of centralization in primary retroperitoneal sarcoma treatment: analysis using hospital-based cancer registry data in Japan.1 passage
• Impact of early tumor reduction on outcome differs by histological subtype in stage III non-small-cell lung cancer treated with definitive radiotherapy.1 passage
• Impact of histologic variants on the oncological outcomes of patients with upper urinary tract cancers treated with radical surgery: a multi-institutional retrospective study.1 passage
• Impact of histology on patterns of failure and clinical outcomes in patients treated with definitive chemoradiotherapy for locally advanced non-small cell lung cancer.1 passage
• Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases.1 passage
• Impact of microscopically margin-positive resection on survival in children with hepatoblastoma after hepatectomy: a retrospective cohort study.1 passage
• Impact of multiple malignancies on surgical outcomes in patients with 1 cm or smaller non-small cell lung cancer.1 passage
• Impact of oral voriconazole during chemotherapy for acute myeloid leukemia and myelodysplastic syndrome: a Japanese nationwide retrospective cohort study.1 passage
• Impact of osteopenia on surgical and oncological outcomes in patients with pancreatic cancer.1 passage
• Impact of pathological stage and histological subtype on clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral uracil-tegafur for non-small cell lung cancer: subanalysis of SLCG0401 trial.1 passage
• Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy with paclitaxel for advanced gastric cancer.1 passage
• Impact of positive surgical margin status in predicting early biochemical recurrence after robot-assisted radical prostatectomy.1 passage
• Impact of preoperative nutritional support and rehabilitation therapy in patients undergoing pancreaticoduodenectomy.1 passage
• Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer.1 passage
• Impact of prostate-specific antigen screening on tumor size in patients with prostate cancer in a super-aging district in Kyoto, Japan.1 passage
• Impact of sarcopenia in advanced and metastatic soft tissue sarcoma.1 passage
• Impact of sarcopenia in patients with advanced or recurrent colorectal cancer treated with regorafenib.1 passage
• Impact of single-heterozygous UGT1A1 on the clinical outcomes of irinotecan monotherapy after fluoropyrimidine and platinum-based combination therapy for gastric cancer: a multicenter retrospective study.1 passage
• Impact of the changes in the completion lymph node dissection criteria and approval of adjuvant therapies on the real-world outcomes of Japanese stage III melanoma patients.1 passage
• Impact of the number of removed lymph nodes on recurrence-free survival in stage I ovarian clear cell carcinoma.1 passage
• Impact of variant histology on disease aggressiveness and outcome after nephroureterectomy in Japanese patients with upper tract urothelial carcinoma.1 passage
• Implementation of a molecular tumor board at a regional level to improve access to targeted therapy.1 passage
• Implication of programmed cell death ligand 1 expression in tumor recurrence and prognosis in rectal cancer with neoadjuvant chemoradiotherapy.1 passage
• Improved oncologic outcomes with increase of laparoscopic surgery in modified complete mesocolic excision with D3 lymph node dissection for T3/4a colon cancer: results of 1191 consecutive patients during a 10-year period: a retrospective cohort study.1 passage
• Improvement of renal function by changing the bone-modifying agent from zoledronic acid to denosumab.1 passage
• Incidence and risk factors for lower limb lymphedema after gynecologic cancer surgery with initiation of periodic complex decongestive physiotherapy.1 passage
• Incidence and risk factors of parastomal hernia after ileal conduit diversion in Japanese population.1 passage
• Incidence and risk factors of synchronous colorectal cancer in patients with esophageal cancer: an analysis of 480 consecutive colonoscopies before surgery.1 passage
• Incidence and severity of adverse events associated with re-irradiation for spine or pelvic bone metastases.1 passage
• Incidence of and risk factors associated with nedaplatin-related hypersensitivity reactions.1 passage
• Incidence of germline variants in Lynch syndrome-related genes among Japanese endometrial cancer patients aged 40 years or younger.1 passage
• Incidence of hypophosphatemia in advanced cancer patients: a recent report from a single institution.1 passage
• Incidence, risk and prognostic role of anti-epidermal growth factor receptor-induced skin rash in biliary cancer: a meta-analysis.1 passage
• Including positive lymph node count in the AJCC N staging may be a better predictor of the prognosis of NSCLC patients, especially stage III patients: a large population-based study.1 passage
• Increased levels of sperm protein 17 mRNA and circulating antibodies in periampullary carcinoma patients.1 passage
• Increased risk of certain second primary malignancies in patients treated for well-differentiated thyroid cancer.1 passage
• Increasing age-related survival gap among patients with colorectal cancer: a population-based retrospective study.1 passage
• Incurable locoregional disease is a strong poor prognostic factor in recurrent or metastatic squamous cell carcinoma of the head and neck.1 passage
• Indications for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in elderly patients with peritoneal malignancy.1 passage
• Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases.1 passage
• Induction TPF chemotherapy followed by CRT with fractionated administration of cisplatin in patients with unresectable locally advanced head and neck cancer.1 passage
• Inflammation-based prognostic scores as indicators to select candidates for primary site resection followed by multimodal therapy among colorectal cancer patients with multiple metastases.1 passage
• Inflammation-nutrition score predicts prognosis of patients with resectable hepatocellular carcinoma.1 passage
• Influence of UGT1A1 polymorphism on etoposide plus platinum-induced neutropenia in Japanese patients with small-cell lung cancer.1 passage
• Influence of VEGFR2 gene polymorphism on the clinical outcomes of apatinib for patients with chemotherapy-refractory extensive-stage SCLC: a real-world retrospective study.1 passage
• Influence of incomplete neoadjuvant chemotherapy on esophageal carcinoma.1 passage
• Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma.1 passage
• Infusion-related reaction to ramucirumab plus FOLFIRI in patients with advanced colorectal cancer.1 passage
• Inhibition of Notch and HIF enhances the antitumor effect of radiation in Notch expressing lung cancer.1 passage
• Inhibition of TMEM16A suppresses growth and induces apoptosis in hepatocellular carcinoma.1 passage
• Initial experience of combined use of photodynamic diagnosis and narrow band imaging for detection of flat urothelial lesion.1 passage
• Interaction of H. pylori with toll-like receptor 2-196 to -174 ins/del polymorphism is associated with gastric cancer susceptibility in southern China.1 passage
• Interim analysis for post-marketing surveillance of dabrafenib and trametinib combination therapy in Japanese patients with unresectable and metastatic melanoma with BRAF V600 mutation.1 passage
• Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer.1 passage
• Intra-corporeal robot-assisted versus open radical cystectomy: a propensity score-matched analysis comparing perioperative and long-term survival outcomes and recurrence patterns.1 passage
• Intracellular accumulation of PD-1 molecules in circulating T lymphocytes in advanced malignant melanoma: an implication for immune evasion mechanism.1 passage
• Intracorporeal versus extracorporeal urinary diversion in robot-assisted radical cystectomy: a systematic review and meta-analysis.1 passage
• Intraoperative allogeneic blood transfusion is associated with adverse oncological outcomes in patients with surgically treated non-metastatic clear cell renal cell carcinoma.1 passage
• Intraoperative radiotherapy for extremity soft-tissue sarcomas: can long-term local control be achieved?1 passage
• Intrathoracic extensive-stage small cell lung cancer: assessment of the benefit of thoracic and brain radiotherapy using the SEER database.1 passage
• Intravesical bacillus Calmette-Guerin therapy after second transurethral resection for primary T1 bladder cancer.1 passage
• Introduction of rectosigmoid colectomy improves survival outcomes in early-stage ovarian cancer patients.1 passage
• Inverse planning in high-dose rate brachytherapy improves quality of life of prostate cancer patients compared with forward planning.1 passage
• Investigation of the clinicopathological features of squamous cell carcinoma of the vulva: a retrospective survey of the Tohoku Gynecologic Cancer Unit.1 passage
• Irinotecan and nedaplatin as salvage therapy for patients with advanced germ cell tumors following intensive treatment with cisplatin-based combination chemotherapies.1 passage
• Is mucinous adenocarcinoma of the endometrium a risk factor for lymph node involvement? A multicenter case-control study.1 passage
• Is scintigraphy necessary to detect migration of 125I seeds after brachytherapy for early prostate cancer?1 passage
• Is there any effect of first-day usage of a totally implantable venous access device on complications?1 passage
• Jab1/Cops5: a promising target for cancer diagnosis and therapy.1 passage
• Japan Society of Clinical Oncology provisional clinical opinion for the diagnosis and use of immunotherapy in patients with deficient DNA mismatch repair tumors, cooperated by Japanese Society of Medical Oncology, First Edition.1 passage
• Japan Society of Gynecologic Oncology guidelines 2011 for the treatment of uterine cervical cancer.1 passage
• Japan Society of Gynecologic Oncology guidelines 2013 for the treatment of uterine body neoplasms.1 passage
• Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of ovarian cancer including primary peritoneal cancer and fallopian tube cancer.1 passage
• Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer.1 passage
• Japan Society of Gynecologic Oncology guidelines 2017 for the treatment of uterine cervical cancer.1 passage
• Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology.1 passage
• Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer.1 passage
• Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer.1 passage
• Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.1 passage
• Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2020 for the Clinical Practice of Hereditary Colorectal Cancer.1 passage
• Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary.1 passage
• Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer.1 passage
• Japanese subgroup analysis of a phase III study of S-1 versus docetaxel in non-small cell lung cancer patients after platinum-based treatment: EAST-LC.1 passage
• KAP1 is overexpressed in hepatocellular carcinoma and its clinical significance.1 passage
• Keratinized strap cells: a rare cytological atypia resembles Anitschkow cells, in human oral neoplasm.1 passage
• Key promoters of tumor hallmarks.1 passage
• Key transporters leading to specific protoporphyrin IX accumulation in cancer cell following administration of aminolevulinic acid in photodynamic therapy/diagnosis.1 passage
• Knowledge base toward understanding actionable alterations and realizing precision oncology.1 passage
• LINC00163 inhibits the invasion and metastasis of gastric cancer cells as a ceRNA by sponging miR-183 to regulate the expression of AKAP12.1 passage
• LINC00943 is correlated with gastric cancer and regulates cancer cell proliferation and chemosensitivity via hsa-miR-101-3p.1 passage
• Laboratory prognostic score for predicting 14-day mortality in terminally ill patients with gynecologic malignancy.1 passage
• Lack of association between interleukin-22 gene polymorphisms and cancer risk: a case-control study and a meta-analysis.1 passage
• Laparoscopic radical cystectomy in octogenarians: analysis of a Japanese multicenter cohort.1 passage
• Laparoscopic versus abdominal radical hysterectomy for stage IB1 cervical cancer patients with tumor size ≤ 2 cm: a case-matched control study.1 passage
• Large and diffuse ductal carcinoma in situ: potentially lethal subtypes of "preinvasive" disease.1 passage
• Late start and insufficient S-1 dose in adjuvant chemotherapy can lead to poor prognosis in stage II/III gastric cancer.1 passage
• Late toxicity of proton beam therapy for patients with the nasal cavity, para-nasal sinuses, or involving the skull base malignancy: importance of long-term follow-up.1 passage
• Leiomyosarcoma: investigation of prognostic factors for risk-stratification model.1 passage
• Leptomeningeal metastases arising from gynecological cancers.1 passage
• Limited benefit of targeted molecular therapy for inferior vena cava thrombus associated with renal cell carcinoma.1 passage
• Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis.1 passage
• Long-term cognitive outcome in adult survivors of an early childhood posterior fossa brain tumour.1 passage
• Long-term efficacy of immune checkpoint inhibitors in non-small cell lung cancer patients harboring MET exon 14 skipping mutations.1 passage
• Long-term follow-up comparing salvage radiation therapy and androgen-deprivation therapy for biochemical recurrence after radical prostatectomy.1 passage
• Long-term influence of adjuvant breast radiotherapy on cognitive function in breast cancer patients treated with conservation therapy.1 passage
• Long-term outcomes and prognostic factors of pulmonary metastasectomy for osteosarcoma and soft tissue sarcoma.1 passage
• Long-term outcomes of definitive external-beam radiotherapy for non-metastatic castration-resistant prostate cancer.1 passage
• Long-term outcomes of individualized management after sentinel lymph-node biopsy for vulvar cancer.1 passage
• Long-term outcomes of intensity-modulated radiation therapy combined with neoadjuvant androgen deprivation therapy under an early salvage policy for patients with T3-T4N0M0 prostate cancer.1 passage
• Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma.1 passage
• Long-term outcomes of postoperative taxane/platinum chemotherapy for early stage cervical cancer: a retrospective study.1 passage
• Long-term results of definitive concurrent chemoradiotherapy for patients with esophageal submucosal cancer (T1bN0M0).1 passage
• Long-term results of fluorescence and indigo carmine blue dye-navigated sentinel lymph node biopsy.1 passage
• Long-term safety of high-dose whole pelvic IMRT for high-risk localized prostate cancer through 10-year follow-up.1 passage
• Longitudinal changes in the quality of life of oral cancer patients during the perioperative period.1 passage
• Loss of ARID1A expression is associated with poor prognosis in patients with stage I/II clear cell carcinoma of the ovary.1 passage
• Low PTEN expression is associated with worse overall survival in head and neck squamous cell carcinoma patients treated with chemotherapy and cetuximab.1 passage
• Low expression of CD40L in tumor-free lymph node of oral cavity cancer related with poor prognosis.1 passage
• Low incidence of late recurrence in patients with intermediate-risk prostate cancer treated by intensity-modulated radiation therapy plus short-term androgen deprivation therapy.1 passage
• Low preoperative serum cholesterol level is associated with aggressive pathologic features and poor cancer-specific survival in patients with surgically treated renal cell carcinoma.1 passage
• Low-dose Gamma Knife radiosurgery plus whole-brain radiation therapy for patients with 5 or more brain metastases with or without meningeal dissemination.1 passage
• Low-dose chemotherapy with methotrexate and vinblastine for patients with desmoid tumors: relationship to CTNNB1 mutation status.1 passage
• Lower accuracy of cytological screening for high-grade squamous intraepithelial neoplasia in women over 50 years of age in Japan.1 passage
• Lung cancer incidence and mortality in relationship to hormone replacement therapy use among women participating in the PLCO trial: a post hoc analysis.1 passage
• Lymph node dissection could bring survival benefits to patients diagnosed with clinically node-negative upper urinary tract urothelial cancer: a population-based, propensity score-matched study.1 passage
• Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma.1 passage
• Lymphatic vessel involvement is predictive for lymph node metastasis and an important prognostic factor in endometrial cancer.1 passage
• Lymphocyte-C-reactive protein ratio as a prognostic marker associated with the tumor immune microenvironment in intrahepatic cholangiocarcinoma.1 passage
• Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma.1 passage
• Lymphopenia after induction chemotherapy correlates with incomplete surgical resection in patients with advanced ovarian cancer.1 passage
• MAGE-A1-6   expression in patients with head and neck squamous cell carcinoma: impact on clinical patterns and oncologic outcomes.1 passage
• MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression.1 passage
• Magnitude of advantage in tumor response contributes to a better correlation between treatment effects on overall survival and progression-free survival: a literature-based meta-analysis of clinical trials in patients with metastatic colorectal cancer.1 passage
• Management and outcome of pediatric Wilms tumor with malignant inferior Vena cava thrombus: largest cohort of single-center experience.1 passage
• Management of elderly patients with head and neck carcinoma: analysis of outcomes for radical versus palliative treatment.1 passage
• Management of gastrointestinal perforation related to radiation.1 passage
• Management of hereditary breast and ovarian cancer.1 passage
• Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer Research.1 passage
• Marriage and fertility in long-term survivors of childhood, adolescent and young adult (AYA) high-grade sarcoma.1 passage
• Matched-pair analysis of patients with advanced hypopharyngeal cancer: surgery versus concomitant chemoradiotherapy.1 passage
• Mechanisms of hormonal therapy resistance in breast cancer.1 passage
• Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.1 passage
• Meta-analysis of randomized clinical trials in the era of individual patient data sharing.1 passage
• Meta-analysis of risk factors associated with oxaliplatin hypersensitivity reactions in cancer patients.1 passage
• Meta-analysis supporting noninferiority of oxaliplatin plus S-1 to cisplatin plus S-1 in first-line treatment of advanced gastric cancer (G-SOX study): indirect comparison with S-1 alone.1 passage
• Metastatic clear cell renal cell carcinoma: computed tomography texture analysis as predictive biomarkers of survival in patients treated with nivolumab.1 passage
• Microdissection testicular sperm extraction in Japanese patients with persistent azoospermia after chemotherapy.1 passage
• Modified albumin-bilirubin grade to predict eligibility for second-line therapies at progression on sorafenib therapy in hepatocellular carcinoma patients.1 passage
• Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells.1 passage
• Molecular pathogenesis of multiple myeloma.1 passage
• Monitoring the estimated glomerular filtration rate (eGFR) in patients with small-cell lung cancer during chemotherapy: equations based on serum creatinine or cystatin C?1 passage
• Monitoring with sensitive tumor markers contributes to decision-making and better prognosis in gastric cancer patients with peritoneal recurrence.1 passage
• Mothers' attitudes in Japan regarding cervical cancer screening correlates with intention to recommend cervical cancer screening for daughters.1 passage
• Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancers.1 passage
• Multi-institutional survey of cancer disparities in disabled patients in the region of northwestern Japan.1 passage
• Multi-panel assay of serum autoantibodies in colorectal cancer.1 passage
• Multicenter phase II study of biweekly CAPIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer (JSWOG-C3 study).1 passage
• Multicenter prospective phase II trial of nivolumab in patients with unresectable or metastatic mucosal melanoma.1 passage
• Multicenter randomized phase II clinical trial of oxaliplatin reintroduction as a third- or later-line therapy for metastatic colorectal cancer-biweekly versus standard triweekly XELOX (The ORION Study).1 passage
• Multidisciplinary evaluation at baseline and during treatment improves the rate of compliance and efficacy of deferasirox in elderly myelodysplastic patients.1 passage
• Multivariate evaluation of Thyroid Imaging Reporting and Data System (TI-RADS) in diagnosis malignant thyroid nodule: application to PCA and PLS-DA analysis.1 passage
• Mutation landscape and tumor mutation burden analysis of Chinese patients with pulmonary sarcomatoid carcinomas.1 passage
• Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS).1 passage
• Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS): first analysis on survival.1 passage
• Nationwide survey of fertility preservation in patients with hematological malignancies in Japan.1 passage
• Natural course of asymptomatic abnormal prostate findings incidentally detected by CT after intravesical BCG therapy.1 passage
• Negative impact of neoadjuvant hormonal therapy on detecting biochemical recurrence after radical prostatectomy.1 passage
• Negative prognostic outcomes of percutaneous transhepatic biliary drainage in distal cholangiocarcinoma: a retrospective analysis using propensity score matching.1 passage
• Neo-adjuvant chemotherapy alone for the locally advanced rectal cancer: a systematic review.1 passage
• Neoadjuvant CAPOX and bevacizumab alone for locally advanced rectal cancer: long-term results from the N-SOG 03 trial.1 passage
• Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of locally advanced esophageal cancer: a population-based analysis.1 passage
• Neoadjuvant chemotherapy followed by radical hysterectomy for stage IB2-to-IIB cervical cancer: a retrospective cohort study.1 passage
• Neoadjuvant chemotherapy with docetaxel and carboplatin followed by radical hysterectomy for stage IB2, IIA2, and IIB patients with non-squamous cell carcinoma of the uterine cervix.1 passage
• Neoadjuvant chemotherapy with trastuzumab, docetaxel, and carboplatin administered every 3 weeks for Japanese women with HER2-positive primary breast cancer: efficacy and safety.1 passage
• Neoadjuvant fractionated stereotactic radiotherapy followed by piecemeal resection of brain metastasis: a case series of 20 patients.1 passage
• Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: a propensity score-matched analysis.1 passage
• Neoadjuvant tyrosine kinase inhibitors in rectal gastrointestinal stromal tumours: a provision for enhanced oncological and functional outcomes.1 passage
• Neutrophil-to-lymphocyte ratio after pazopanib treatment predicts response in patients with advanced soft-tissue sarcoma.1 passage
• Neutrophil-to-lymphocyte ratio as an early marker of outcomes in patients with advanced non-small-cell lung cancer treated with nivolumab.1 passage
• Neutrophil-to-lymphocyte ratio predicts metachronous liver metastasis of pancreatic neuroendocrine tumors.1 passage
• Next-generation sequencing-based clinical sequencing: toward precision medicine in solid tumors.1 passage
• Nivolumab in patients with unresectable locally advanced or metastatic urothelial carcinoma: CheckMate 275 2-year global and Japanese patient population analyses.1 passage
• No significant impact of response to prior androgen receptor-axis-targeted agents on the efficacy of subsequent docetaxel in patients with metastatic castration-resistant prostate cancer.1 passage
• Nomogram predicting long-term survival after the diagnosis of intrahepatic recurrence of hepatocellular carcinoma following an initial liver resection.1 passage
• Nomograms predict survival of patients with small bowel adenocarcinoma: a SEER-based study.1 passage
• Non-significant impact of proteinuria on renal function in Japanese patients with metastatic renal cell carcinoma treated with axitinib.1 passage
• Novel classification of ovarian metastases originating from colorectal cancer by radiological imaging and macroscopic appearance.1 passage
• Novel graded prognostic assessment for colorectal cancer patients with brain metastases.1 passage
• Nutritional care of cancer patients: a survey on patients' needs and medical care in reality.1 passage
• Observational study of chemotherapy-induced Clostridium difficile infection in patients with lung cancer.1 passage
• Omental metastasis as a predictive risk factor for unfavorable prognosis in patients with stage III-IV epithelial ovarian cancer.1 passage
• On-treatment C-reactive protein control could predict response to subsequent anti-PD-1 treatment in metastatic renal cell carcinoma.1 passage
• Oncogenic human papillomavirus is not helpful for cytology screening of the precursor lesions of anal cancers in Taiwanese men who are infected with human immunodeficiency virus.1 passage
• Oncologic and obstetric outcomes and complications during pregnancy after fertility-sparing abdominal trachelectomy for cervical cancer: a retrospective review.1 passage
• Oncologic and reproductive outcomes of cystectomy as a fertility-sparing treatment for early-stage epithelial ovarian cancer.1 passage
• Oncologic outcomes and safety of percutaneous cryoablation for biopsy-proven renal cell carcinoma up to 4 cm in diameter: a prospective observational study.1 passage
• Oncologic outcomes for open and laparoscopic radical nephroureterectomy in patients with upper tract urothelial carcinoma.1 passage
• Oncologic outcomes for patients with endometrial cancer who received minimally invasive surgery: a retrospective observational study.1 passage
• Oncological benefit of primary tumor resection with high tie lymph node dissection in unresectable colorectal cancer with synchronous peritoneal metastasis: a propensity score analysis of data from a multi-institute database.1 passage
• Oncological outcomes after cytoreductive nephrectomy for patients with metastatic renal cell carcinoma with inferior vena caval tumor thrombus.1 passage
• Oncolytic virus combined with traditional treatment versus traditional treatment alone in patients with cancer: a meta-analysis.1 passage
• One-step nucleic acid amplification (OSNA): where do we go with it?1 passage
• Operation for locally advanced cervical cancer after concurrent chemoradiotherapy.1 passage
• Opioid needs of terminally ill patients with gynecologic malignancies.1 passage
• Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with gastrointestinal cancer.1 passage
• Optimal management of immune-related adverse events resulting from treatment with immune checkpoint inhibitors: a review and update.1 passage
• Optimal maximum duration for delaying salvage operation when recurrence of retroperitoneal liposarcoma is suspected: a single-center study.1 passage
• Optimal strength and timing of steroids in the management of erlotinib-related skin toxicities in a post-marketing surveillance study (POLARSTAR) of 9909 non-small-cell lung cancer patients.1 passage
• Optimal treatment strategy for paratesticular liposarcoma: retrospective analysis of 265 reported cases.1 passage
• Optimal treatment strategy for rectal cancer based on the risk factors for recurrence patterns.1 passage
• Optimal use of anthracycline-free perioperative chemotherapy in HER2-positive breast cancer patients.1 passage
• Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015  Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis.1 passage
• Optimizing biopsy procedures during colposcopy for women with abnormal cervical cancer screening results: a multicenter prospective study.1 passage
• Oral administration of the amino acids cystine and theanine attenuates the adverse events of S-1 adjuvant chemotherapy in gastrointestinal cancer patients.1 passage
• Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B).1 passage
• Osteogenic and brain metastases after non-small cell lung cancer resection.1 passage
• Otorhinolaryngologists/head and neck surgeons' knowledge, attitudes, and practices regarding fertility preservation in young cancer patients treated with chemotherapy: an anonymous questionnaire survey.1 passage
• Outcome of patients with newly diagnosed primary CNS lymphoma after high-dose methotrexate followed by consolidation whole-brain radiotherapy and cytarabine: an 8-year cohort study.1 passage
• Outcome of patients with primary retroperitoneal solitary fibrous sarcoma.1 passage
• Outcomes of abdominal radical trachelectomy: results of a multicenter prospective cohort study in a Tohoku Gynecologic Cancer Unit.1 passage
• Outcomes of curative nephrectomy against renal cell carcinoma based on a central pathological review of 914 specimens from the era of cytokine treatment.1 passage
• Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study.1 passage
• Outcomes of non-metastatic colon cancer patients in relationship to socioeconomic status: an analysis of SEER census tract-level socioeconomic database.1 passage
• Outcomes of patients with non-small cell lung cancer and poor performance status treated with immune checkpoint inhibitors in the real-world setting.1 passage
• Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients.1 passage
• Outcomes of very elderly patients with aggressive B-cell non-Hodgkin lymphoma treated with reduced-dose chemotherapy.1 passage
• Overall survival and prognostic factors in patients with spinal metastases from lung cancer treated with and without epidermal growth factor receptor tyrosine kinase inhibitors.1 passage
• Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.1 passage
• Overexpression of Cullin4A correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.1 passage
• Overweight and obesity as risk factors for biochemical recurrence of prostate cancer after radical prostatectomy.1 passage
• Oxaliplatin-induced increase in splenic volume: experiences from multicenter study in Japan.1 passage
• PD-1/PD-L1 blockade in cancer treatment: perspectives and issues.1 passage
• PD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD81 passage
• PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer.1 passage
• PLEKHG5 is a novel prognostic biomarker in glioma patients.1 passage
• Palbociclib as an early-line treatment for Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: a review of clinical trial and real-world data.1 passage
• Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients.1 passage
• Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients.1 passage
• Palliative radiotherapy and chemoradiotherapy in stage IVA/B esophageal cancer patients with dysphagia.1 passage
• Partial nephrectomy for hilar tumors: comparison of conventional open and robot-assisted approaches.1 passage
• Patient perceptions of symptoms and concerns during cancer chemotherapy: 'affects my family' is the most important.1 passage
• Patterns of lymph node metastasis and the management of neck dissection for parotid carcinomas: a single-institute experience.1 passage
• Pelvic reconstruction using an ice-cream cone prosthesis: correlation between the inserted length of the coned stem and surgical outcome.1 passage
• Pembrolizumab plus axitinib versus sunitinib in metastatic renal cell carcinoma: outcomes of Japanese patients enrolled in the randomized, phase III, open-label KEYNOTE-426 study.1 passage
• Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045 trial.1 passage
• Perception and needs of reproductive specialists with regard to fertility preservation of young breast cancer patients.1 passage
• Percutaneous biliary stent with intraluminal brachytherapy versus palliative surgery in the management of extrahepatic cholangiocarcinoma.1 passage
• Percutaneous cryoablation for advanced and refractory extra-abdominal desmoid tumors.1 passage
• Performance of p16INK4a/Ki-67 immunocytochemistry for identifying CIN2+ in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion specimens: a Japanese Gynecologic Oncology Group study.1 passage
• Performance of three prognostic models in critically ill patients with cancer: a prospective study.1 passage
• Peri-operative efficacy and long-term survival benefit of robotic-assisted radical cystectomy in septuagenarian patients compared with younger patients: a nationwide multi-institutional study in Japan.1 passage
• Perspectives for circulating tumor DNA in clinical management of colorectal cancer.1 passage
• Perspectives of Japanese oncologists on the health economics of innovative cancer treatments.1 passage
• Pertuzumab plus trastuzumab and chemotherapy for Japanese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subgroup analysis of the JACOB trial.1 passage
• Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeutic and biomarker results.1 passage
• Pharmacokinetics of S-1 monotherapy in plasma and in tears for gastric cancer patients.1 passage
• Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma.1 passage
• Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer.1 passage
• Phase I study of napabucasin in combination with FOLFIRI + bevacizumab in Japanese patients with metastatic colorectal cancer.1 passage
• Phase I study of primary treatment with 5-FU, oxaliplatin, irinotecan, levofolinate, and panitumumab combination chemotherapy in patients with advanced/recurrent colorectal cancer involving the wild-type RAS gene: the JACCRO CC-14 study.1 passage
• Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1).1 passage
• Phase I trial of neoadjuvant preoperative chemotherapy with S-1, oxaliplatin, and bevacizumab plus radiation in patients with locally advanced rectal cancer.1 passage
• Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass.1 passage
• Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study).1 passage
• Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.1 passage
• Phase II multi-institutional prospective randomized trial comparing S-1 plus paclitaxel with paclitaxel alone as second-line chemotherapy in S-1 pretreated gastric cancer (CCOG0701).1 passage
• Phase II multi-institutional prospective trial of nab-paclitaxel as second-line chemotherapy for advanced gastric cancer refractory to fluoropyrimidine with modified dose reduction criteria (CCOG1303).1 passage
• Phase II study of 5-fluorouracil-leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802).1 passage
• Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER).1 passage
• Phase II study of S-1 plus oxaliplatin 130 mg/m1 passage
• Phase II study of S-1-based sequential combination chemotherapy including oxaliplatin plus bevacizumab and irinotecan with or without cetuximab for metastatic colorectal cancer: the SOBIC trial.1 passage
• Phase II study of a new multidisciplinary therapy using once every 3 week carboplatin plus dose-dense weekly paclitaxel before and after radical hysterectomy for locally advanced cervical cancer.1 passage
• Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II).1 passage
• Phase II study of carboplatin, docetaxel and bevacizumab for chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancer.1 passage
• Phase II study of docetaxel, cisplatin, and concurrent radiation followed by platinum-based adjuvant chemotherapy for technically unresectable, locally advanced head and neck squamous cell carcinoma.1 passage
• Phase II study of first-line chemotherapy with uracil-tegafur plus oral leucovorin in elderly (≥75 years) Japanese patients with metastatic colorectal cancer: SGOSG-CR0501 study.1 passage
• Phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer.1 passage
• Phase II study of the combination of S-1 with bevacizumab for patients with previously treated advanced non-squamous non-small-cell lung cancer.1 passage
• Phase II trial of an alternating regimen consisting of first-line mFOLFOX6 plus bevacizumab and FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer: FIREFOX plus bevacizumab trial (KSCC0801).1 passage
• Phase II trial of combination treatment with S-1/cetuximab in patients with platinum-ineligible recurrent and/or metastatic squamous cell carcinoma of the head and neck.1 passage
• Phase II trial of subcutaneous methylnaltrexone in the treatment of severe opioid-induced constipation (OIC) in cancer patients: an exploratory study.1 passage
• Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB-IIIA non-small cell lung cancer (WJTOG0101).1 passage
• Phonatory function in patients with well-differentiated thyroid carcinoma following meticulous resection of tumors adhering to the recurrent laryngeal nerve.1 passage
• Photodynamic diagnosis and therapy for urothelial carcinoma and prostate cancer: new imaging technology and therapy.1 passage
• Physical and social characteristics and support needs of adult female childhood cancer survivors who underwent hormone replacement therapy.1 passage
• Plasma DNA methylation of p16 and shp1 in patients with B cell non-Hodgkin lymphoma.1 passage
• Plasma concentrations of dasatinib have a clinical impact on the frequency of dasatinib dose reduction and interruption in chronic myeloid leukemia: an analysis of the DARIA 01 study.1 passage
• Polymorphism of TUSC7 associated with gastric cancer susceptibility and binding with miR-133a-3p: a population-based case-control study.1 passage
• Polymorphisms of MTHFR C677T and A1298C associated with survival in patients with colorectal cancer treated with 5-fluorouracil-based chemotherapy.1 passage
• Positive node burden rather than the number of removed nodes impacts survival in patients with node-positive prostate cancer.1 passage
• Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.1 passage
• Post-operative pulmonary and shoulder function after sternal reconstruction for patients with chest wall sarcomas.1 passage
• Post-recurrence chemotherapy for mesothelioma patients undergoing extrapleural pneumonectomy.1 passage
• Postoperative C-reactive protein/albumin ratio is a biomarker of risk of recurrence and need for adjuvant chemotherapy for stage III colorectal cancer.1 passage
• Postoperative D-dimer elevation affects tumor recurrence and the long-term survival in gastric cancer patients who undergo gastrectomy.1 passage
• Postoperative weight loss leads to poor survival through poor S-1 efficacy in patients with stage II/III gastric cancer.1 passage
• Postradiotherapy persistent lymphopenia as a poor prognostic factor in patients with cervical cancer receiving radiotherapy: a single-center, retrospective study.1 passage
• Potential intrinsic subtype dependence on the association between metformin use and survival in surgically resected breast cancer: a Korean national population-based study.1 passage
• Potential predictive factors for microvascular invasion in hepatocellular carcinoma classified within the Milan criteria.1 passage
• Practical guidance for the evaluation of disease progression and the decision to change treatment in patients with advanced gastric cancer receiving chemotherapy.1 passage
• Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.1 passage
• Pre-treatment ratio of periprostatic to subcutaneous fat thickness on MRI is an independent survival predictor in hormone-naïve men with advanced prostate cancer.1 passage
• Precision medicine and novel molecular target therapies in acute myeloid leukemia: the background of hematologic malignancies (HM)-SCREEN-Japan 01.1 passage
• Precision medicine for ovarian clear cell carcinoma based on gene alterations.1 passage
• Predicting factors for progression to castration resistance prostate cancer after biochemical recurrence in patients with clinically localized prostate cancer who underwent radical prostatectomy.1 passage
• Predicting marker for early progression in unresectable melanoma treated with nivolumab.1 passage
• Predicting short-term life expectancy of patients with end-stage gastric cancer using Onodera's prognostic nutritional index.1 passage
• Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institution.1 passage
• Predictive factors for severe and febrile neutropenia during docetaxel chemotherapy for castration-resistant prostate cancer.1 passage
• Predictive factors for short-term biochemical recurrence-free survival after robot-assisted laparoscopic radical prostatectomy in high-risk prostate cancer patients.1 passage
• Predictive factors of rectal hemorrhage in patients with localized prostate cancer who underwent low-dose-rate brachytherapy.1 passage
• Predictive factors of survival of colorectal cancer patients after para-aortic lymph node metastasis.1 passage
• Predictive markers of chemoradiotherapy for rectal cancer: comparison of biopsy specimens taken before and about 1 week after the start of chemoradiotherapy.1 passage
• Predictive markers, including total lesion glycolysis, for the response of lymph node(s) metastasis from head and neck squamous cell carcinoma treated by chemoradiotherapy.1 passage
• Predictive role of γ-glutamyltransferase in patients receiving nivolumab therapy for metastatic renal cell carcinoma.1 passage
• Predictive value of1 passage
• Predictors for recurrent/persistent high-grade intraepithelial lesions and cervical stenosis after therapeutic conization: a retrospective analysis of 522 cases.1 passage
• Predictors of favorable survival after secondary cytoreductive surgery for recurrent endometrial cancer.1 passage
• Predictors of long-term survival in patients with stage IV colorectal cancer with multi-organ metastases: a single-center retrospective analysis.1 passage
• Predictors of the need for prophylactic percutaneous endoscopic gastrostomy in head and neck cancer patients treated with concurrent chemoradiotherapy.1 passage
• Predisposing factors and clinical impact of high-output syndrome after sphincter-preserving surgery with covering ileostomy for rectal cancer: a retrospective single-center cohort study.1 passage
• Pregnancy does not increase the local recurrence rate after surgical resection of desmoid-type fibromatosis.1 passage
• Preoperative biliary drainage-related inflammation is associated with shorter survival in biliary tract cancer patients.1 passage
• Preoperative differentiation between benign and malignant renal masses smaller than 4 cm treated with partial nephrectomy.1 passage
• Preoperative hydronephrosis as a predictor of postnephroureterectomy survival in patients with upper tract urothelial carcinoma: a two-center study in Japan.1 passage
• Preoperative iron status is a prognosis factor for stage II and III colorectal cancer.1 passage
• Preoperative lymphocyte-to-monocyte ratio predicts postoperative infectious complications after laparoscopic colorectal cancer surgery.1 passage
• Preoperative models incorporating the systemic immune-inflammation index for predicting prognosis and muscle invasion in patients with non-metastatic upper tract urothelial carcinoma.1 passage
• Preoperative platelet-lymphocyte ratio is an independent prognostic marker and superior to carcinoembryonic antigen in colorectal peritoneal carcinomatosis patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.1 passage
• Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer.1 passage
• Preoperative predictive factors focused on inflammation-, nutrition-, and muscle-status in patients with upper urinary tract urothelial carcinoma undergoing nephroureterectomy.1 passage
• Preoperative predictors of difficult hypopharyngeal exposure by retractor for transoral robotic surgery.1 passage
• Preoperative predictors of dysphagia after transoral surgery.1 passage
• Preoperative risk stratification for cancer-specific survival of patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy.1 passage
• Preoperative sarcopenia is a poor prognostic factor in lower rectal cancer patients undergoing neoadjuvant chemoradiotherapy: a retrospective study.1 passage
• Preoperative transferrin level is a novel indicator of short- and long-term outcomes after esophageal cancer surgery.1 passage
• Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer.1 passage
• Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers.1 passage
• Present clinical practices of stereotactic irradiation for metastatic brain tumors in Japan: results of questionnaire survey of the Japanese Radiation Oncology Study Group (JROSG) working subgroup for neurological tumors.1 passage
• Preservation of fertility of adult male cancer patients treated with chemotherapy.1 passage
• Presurgical axitinib therapy increases fibrotic reactions within tumor thrombus in renal cell carcinoma with thrombus extending to the inferior vena cava.1 passage
• Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis.1 passage
• Pretreatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with metastatic renal cell carcinoma receiving targeted therapy.1 passage
• Pretreatment predictive factors for feasibility of oral intake in adjuvant concurrent chemoradiotherapy for patients with locally advanced squamous cell carcinoma of the head and neck.1 passage
• Prevalence of laparoscopic surgical treatment and its clinical outcomes in patients with familial adenomatous polyposis in Japan.1 passage
• Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study.1 passage
• Primary prophylactic granulocyte colony-stimulating factor according to ASCO guidelines has no preventive effect on febrile neutropenia in patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy.1 passage
• Primary tracheal adenoid cystic carcinoma: adjuvant treatment outcome.1 passage
• Pro-gastrin-releasing peptide as a marker for the Ewing sarcoma family of tumors.1 passage
• Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era.1 passage
• Prognostic analysis of surgically treated clear cell sarcoma: an analysis of a rare tumor from a single center.1 passage
• Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer.1 passage
• Prognostic factors after imatinib secondary resistance: survival analysis in patients with unresectable and metastatic gastrointestinal stromal tumors.1 passage
• Prognostic factors and survival in Japanese patients with brain metastasis from renal cell cancer.1 passage
• Prognostic factors for cytology-positive gastric cancer: a multicenter retrospective analysis.1 passage
• Prognostic factors for disease-free and overall survival of patients with uterine carcinosarcoma.1 passage
• Prognostic factors in Chinese patients with prostate cancer receiving primary androgen deprivation therapy: validation of Japan Cancer of the Prostate Risk Assessment (J-CAPRA) score and impacts of pre-existing obesity and diabetes mellitus.1 passage
• Prognostic factors in patients who received end-of-life chemotherapy for advanced cancer.1 passage
• Prognostic factors in patients with metastatic urothelial carcinoma who have treated with Atezolizumab.1 passage
• Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.1 passage
• Prognostic impact of a single-nucleotide polymorphism near the CTSO gene in hormone receptor-positive breast cancer patients.1 passage
• Prognostic impact of bone metastatic volume beyond vertebrae and pelvis in patients with metastatic hormone-sensitive prostate cancer.1 passage
• Prognostic impact of completion of initial high-dose methotrexate therapy on primary central nervous system lymphoma: a single institution experience.1 passage
• Prognostic impact of neutrophilia and lymphopenia on survival in anal cancer treated with definitive concurrent chemoradiotherapy: a retrospective multicenter study.1 passage
• Prognostic impact of preoperative FDG-PET positive lymph nodes in lung cancer.1 passage
• Prognostic impact of preoperative renal function in patients treated with radical cystectomy: a multi-institutional retrospective study.1 passage
• Prognostic impact of the subclassification of Müllerian cancer stage IV in the FIGO 2014 staging system with a focus of extra-abdominal lymph node metastases.1 passage
• Prognostic impact of underlying lung disease in pulmonary wedge resection for lung cancer.1 passage
• Prognostic impacts of postoperative complications in patients with intrahepatic cholangiocarcinoma after curative operations.1 passage
• Prognostic implication of adjuvant/neoadjuvant chemotherapy consisting of doxorubicin and ifosfamide in patients with extraskeletal osteosarcoma.1 passage
• Prognostic implications of receptor discordance between primary and recurrent breast cancer.1 passage
• Prognostic model for survival based on readily available pretreatment factors in patients with advanced pancreatic cancer receiving palliative chemotherapy.1 passage
• Prognostic outcome and complications of sentinel lymph node navigation surgery for early-stage cervical cancer.1 passage
• Prognostic outcomes and risk factors for recurrence after laser vaporization for cervical intraepithelial neoplasia: a single-center retrospective study.1 passage
• Prognostic outcomes and safety in patients treated with pembrolizumab for advanced urothelial carcinoma: experience in real-world clinical practice.1 passage
• Prognostic relevance of ATM protein in uveal melanoma and its association with clinicopathological factors.1 passage
• Prognostic relevance of stromal CD26 expression in rectal cancer after chemoradiotherapy.1 passage
• Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study.1 passage
• Prognostic significance of NADPH oxidase-4 as an indicator of reactive oxygen species stress in human retinoblastoma.1 passage
• Prognostic significance of hyperfibrinogenemia in patients with esophageal squamous cell carcinoma.1 passage
• Prognostic significance of hyponatremia induced by systemic chemotherapy in a hospital-based propensity score-matched analysis.1 passage
• Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET-CT metabolic parameters in small cell lung cancer (SCLC).1 passage
• Prognostic significance of pathological response to preoperative chemoradiotherapy in patients with locally advanced rectal cancer.1 passage
• Prognostic significance of peritoneal cytology in low-risk endometrial cancer: comparison of laparoscopic surgery and laparotomy.1 passage
• Prognostic significance of preoperative plasma fibrinogen levels in primary gastrointestinal stromal tumours: a retrospective cohort study.1 passage
• Prognostic significance of serum p53 antibody according to KRAS status in metastatic colorectal cancer patients.1 passage
• Prognostic significance of solid growth in endometrioid endometrial adenocarcinoma.1 passage
• Prognostic significance of third-line treatment for patients with metastatic castration-resistant prostate cancer: comparative assessments between cabazitaxel and other agents.1 passage
• Prognostic significance of β2-adrenergic receptor expression in patients with surgically resected colorectal cancer.1 passage
• Prognostic value of PSA bounce after definitive radiotherapy revisited.1 passage
• Prognostic value of alkaline phosphatase in hormone-sensitive prostate cancer: a systematic review and meta-analysis.1 passage
• Prognostic value of glucosylceramide synthase and P-glycoprotein expression in oral cavity cancer.1 passage
• Prognostic value of hematological parameters in patients undergoing esophagectomy for esophageal squamous cell carcinoma.1 passage
• Prognostic value of pre-treatment risk stratification and post-treatment neutrophil/lymphocyte ratio change for pembrolizumab in patients with advanced urothelial carcinoma.1 passage
• Prognostic value of preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer.1 passage
• Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis.1 passage
• Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma.1 passage
• Prognostic value of serum C-reactive protein level prior to second-line treatment in intermediate risk metastatic renal cell carcinoma patients.1 passage
• Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis.1 passage
• Prognostic value of the AJCC 8th edition staging system for Japanese patients treated with surgery followed by radiotherapy for breast cancer.1 passage
• Prognostic value of the Glasgow Prognostic Score for patients with metastatic renal cell carcinoma treated by cytoreductive nephrectomy.1 passage
• Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy.1 passage
• Prognostic value of tumor deposits in locally advanced rectal cancer: a retrospective study with propensity score matching.1 passage
• Progress on treatment of MET signaling pathway in non-small cell lung cancer.1 passage
• Prolonged conservative treatment in patients with recurrent endometrial cancer after primary fertility-sparing therapy: 15-year experience.1 passage
• Prophylactic efficacy of ninjin'yoeito for oxaliplatin-induced cumulative peripheral neuropathy in patients with colorectal cancer receiving postoperative adjuvant chemotherapy: a randomized, open-label, phase 2 trial (HOPE-2).1 passage
• Proposal for selection criteria of secondary cytoreductive surgery in recurrent epithelial ovarian, tubal, and peritoneal cancers.1 passage
• Prospective evaluation of the safety of transrectal ultrasound-guided transperineal prostate biopsy based on adverse events.1 passage
• Prospective feasibility study of neoadjuvant dose-dense paclitaxel plus carboplatin with bevacizumab therapy followed by interval debulking surgery for advanced ovarian, fallopian tube, and primary peritoneal cancer patients.1 passage
• Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy.1 passage
• Prostate-specific antigen measured 3 months after radical prostatectomy as a new predictor of biochemical recurrence.1 passage
• Protective effect of the oral administration of cystine and theanine on oxaliplatin-induced peripheral neuropathy: a pilot randomized trial.1 passage
• Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma.1 passage
• Psychological impact of breast cancer screening in Japan.1 passage
• Psychological impact of positive cervical cancer screening results among Japanese women.1 passage
• Psychological impact of serial prostate-specific antigen tests in Japanese men waiting for prostate biopsy.1 passage
• Putative risk factors for postoperative pneumonia which affects poor prognosis in patients with gastric cancer.1 passage
• Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma.1 passage
• Quantitative analysis of the BRAF1 passage
• R.E.N.A.L. nephrometry score predicts postoperative recurrence of localized renal cell carcinoma treated by radical nephrectomy.1 passage
• RFA experiences, indications and clinical outcomes.1 passage
• Radiation therapy versus surgery for patients with cervical squamous cell carcinoma who have undergone neoadjuvant chemotherapy revisited.1 passage
• Radiation-related toxicities and outcomes in endometrial cancer: are obese women at a disadvantage?1 passage
• Radical hysterectomy with or without para-aortic lymphadenectomy for patients with stage IB2, IIA2, and IIB cervical cancer: outcomes for a series of 308 patients.1 passage
• Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.1 passage
• Radiotherapy combined with zoledronate can reduce skeletal-related events in renal cell carcinoma patients with bone metastasis.1 passage
• Radiotherapy for thoracic tumors: association between subclinical interstitial lung disease and fatal radiation pneumonitis.1 passage
• Radiotherapy for vaginal cancer: a multi-institutional survey study of the Japanese Radiation Oncology Study Group.1 passage
• Radiotherapy role in non-seminomatous germ cell tumors, radiobiological and technical issues of an unexplored scenario.1 passage
• Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701.1 passage
• Randomized phase II study of daily and alternate-day administration of S-1 for advanced gastric cancer (JFMC43-1003).1 passage
• Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302.1 passage
• Rapid decrease of serum alpha-fetoprotein and tumor volume predicts outcome in children with hepatoblastoma treated with neoadjuvant chemotherapy.1 passage
• Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment.1 passage
• Real-world clinical outcomes and prognostic factors in Japanese patients with recurrent or metastatic squamous cell carcinoma of head and neck treated with chemotherapy plus cetuximab: a prospective observation study (JROSG12-2).1 passage
• Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance.1 passage
• Real-world safety and effectiveness of radium-223 in Japanese patients with castration-resistant prostate cancer (CRPC) and bone metastasis: exploratory analysis, based on the results of post-marketing surveillance, according to prior chemotherapy status and in patients without concomitant use of second-generation androgen-receptor axis-targeted agents.1 passage
• Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib.1 passage
• Real-world use of enzalutamide in men with nonmetastatic castration-resistant prostate cancer in Japan.1 passage
• Recent advances in medical therapy for metastatic urothelial cancer.1 passage
• Recent advances in multidisciplinary approach for rectal cancer.1 passage
• Recent advances in robotic surgery for rectal cancer.1 passage
• Recent advances in targeting DNA repair pathways for the treatment of ovarian cancer and their clinical relevance.1 passage
• Recent advances in therapeutic strategies for unresectable or metastatic melanoma and real-world data in Japan.1 passage
• Recent advances of the regulation roles of MicroRNA in glioblastoma.1 passage
• Recent progress and perspectives on prostate cancer biomarkers.1 passage
• Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan.1 passage
• Recent trends for drug lag in clinical development of oncology drugs in Japan: does the oncology drug lag still exist in Japan?1 passage
• Recent trends in population-based cancer registries in Japan: the Act on Promotion of Cancer Registries and drastic changes in the historical registry.1 passage
• Recognition and attitudes of Japanese hematologists on sperm banking before chemotherapy: present status from nationwide questionnaire survey.1 passage
• Recombinant human soluble thrombomodulin (thrombomodulin alfa) to treat disseminated intravascular coagulation in solid tumors: results of a one-arm prospective trial.1 passage
• Regorafenib for advanced gastrointestinal stromal tumors following imatinib and sunitinib treatment: a subgroup analysis evaluating Japanese patients in the phase III GRID trial.1 passage
• Relationship between diverting stoma and adjuvant chemotherapy in patients with rectal cancer: a nationwide study using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.1 passage
• Relationship between quality of life instruments and phonatory function in tracheoesophageal speech with voice prosthesis.1 passage
• Relationships between sunitinib plasma concentration and clinical outcomes in Japanese patients with metastatic renal cell carcinoma.1 passage
• Removal of the entire internal iliac vessel system is a feasible surgical procedure for locally advanced ovarian carcinoma adhered firmly to the pelvic sidewall.1 passage
• Repeat cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal carcinomatosis of appendiceal origin.1 passage
• Reply to Cengiz Beyan and Esin Beyan. Mean platelet volume may not be a significant prognostic factor in patients with metastatic castration-resistant prostate cancer. Int J Clin Oncol 97(2), 3-4, 2020.1 passage
• Research misconduct and data fraud in clinical trials: prevalence and causal factors.1 passage
• Research on the predicting power of the revised Tokuhashi system: how much time can surgery give to patients with short life expectancy?1 passage
• Resection of pancreatic metastatic renal cell carcinoma: experience and long-term survival outcome from a large center in China.1 passage
• Response to first-line chemotherapy regimen is associated with efficacy of ımmune checkpoint blockade therapies in patients with metastatic urothelial carcinoma.1 passage
• Response to the treatment immediately before nivolumab monotherapy may predict clinical response to nivolumab in patients with non-small cell lung cancer.1 passage
• Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).1 passage
• Results of weekday-on and weekend-off administration schedule of sunitinib therapy for advanced renal cell carcinoma.1 passage
• Rethinking of treatment strategies and clinical management in ovarian clear cell carcinoma.1 passage
• Retrospective analysis for the efficacy and safety of nivolumab in advanced gastric cancer patients according to ascites burden.1 passage
• Retrospective analysis of first-line treatment for follicular lymphoma based on outcomes and medical economics.1 passage
• Retrospective analysis of lung cancer patients treated with supportive care alone.1 passage
• Retrospective analysis of neoadjuvant chemotherapy followed by surgery versus definitive chemoradiotherapy with proton beam for locally advanced esophageal squamous cell carcinoma.1 passage
• Retrospective analysis on the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumors.1 passage
• Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis.1 passage
• Retrospective study on bevacizumab in the treatment of non-small cell lung cancer with brain metastases.1 passage
• Review and proposal of regional surgical management for melanoma: revisiting of integumentectomy and incontinuity dissection in treatment of skin melanoma.1 passage
• Risk assessment of multi-factorial complications after transrectal ultrasound-guided prostate biopsy: a single institutional retrospective cohort study.1 passage
• Risk factors and oncological outcomes of urethral recurrence in male patients with muscle invasive bladder cancer after radical cystectomy combined with urinary diversion: a propensity score-matched case control study.1 passage
• Risk factors and prognostic significance of lateral pelvic lymph node metastasis in advanced rectal cancer.1 passage
• Risk factors for cardiovascular mortality in patients with colorectal cancer: a population-based study.1 passage
• Risk factors for gemcitabine plus nab-paclitaxel-induced interstitial lung disease in pancreatic cancer patients.1 passage
• Risk factors for joint symptoms in postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes.1 passage
• Risk factors for lower limb lymphedema in gynecologic cancer patients after initial treatment.1 passage
• Risk factors for lymph node metastasis in cutaneous squamous cell carcinoma: a long-term retrospective study of Japanese patients.1 passage
• Risk factors for metachronous colorectal cancer in Lynch syndrome patients: a registry-based observational mono-institutional study cohort.1 passage
• Risk factors for paraaortic lymph node metastasis in endometrial cancer.1 passage
• Risk factors of early recurrence within 6 months after esophagectomy following neoadjuvant chemotherapy for resectable advanced esophageal squamous cell carcinoma.1 passage
• Risk factors of mFOLFOX6-induced hyperammonemia in patients with colorectal cancer: an observational study.1 passage
• Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan.1 passage
• Risk of fatigue in cancer patients receiving anti-EGFR monoclonal antibodies: results from a systematic review and meta-analysis of randomized controlled trial.1 passage
• Risk of second malignancies among survivors of pediatric thyroid cancer.1 passage
• Risk scores as useful predictors of perioperative complications in patients with rectal cancer who received radical surgery.1 passage
• Robot-assisted radical cystectomy is a promising alternative to open surgery in the Japanese population with a high rate of octogenarians.1 passage
• Robotic-assisted breast-axillo insufflation thyroidectomy (RABIT): a retrospective case series of thyroid carcinoma.1 passage
• Role of bevacizumab in neoadjuvant chemotherapy and its influence on microvessel density in rectal cancer.1 passage
• Role of intensive nutrition support and prophylactic percutaneous endoscopic gastrostomy during concomitant chemoradiotherapy for oropharyngeal cancer.1 passage
• Role of sentinel lymph node biopsy in patients with Merkel cell carcinoma: statistical analysis of 403 reported cases.1 passage
• Role of the DEK oncogene in the development of squamous cell carcinoma.1 passage
• S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102).1 passage
• SAMD14 promoter methylation is strongly associated with gene expression and poor prognosis in gastric cancer.1 passage
• SERPINE2 is an oral cancer-promoting factor that induces angiogenesis and lymphangiogenesis.1 passage
• STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy.1 passage
• Saddle pulmonary embolism and in-hospital mortality in patients with cancer.1 passage
• Safety and efficacy of S-1 plus oxaliplatin 130 mg/m1 passage
• Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.1 passage
• Safety and efficacy of panitumumab in combination with trifluridine/tipiracil for pre-treated patients with unresectable, metastatic colorectal cancer with wild-type RAS: The phase 1/2 APOLLON study.1 passage
• Safety and efficacy of radium-223 dichloride in Japanese patients with castration-resistant prostate cancer and bone metastases.1 passage
• Safety of radiotherapy for hemodialysis patients with cancer.1 passage
• Safety, pharmacokinetics and efficacy findings in an open-label, single-arm study of weekly paclitaxel plus lapatinib as first-line therapy for Japanese women with HER2-positive metastatic breast cancer.1 passage
• Salivary metabolites to detect patients with cancer: a systematic review.1 passage
• Salvage endoscopic nasopharyngectomy for local recurrent or residual nasopharyngeal carcinoma: a 10-year experience.1 passage
• Sarcopenia as a significant predictive factor of neutropenia and overall survival in urothelial carcinoma patients underwent gemcitabine and cisplatin or carboplatin.1 passage
• Sarcopenia is associated with survival in patients with urothelial carcinoma treated with systemic chemotherapy.1 passage
• Sarcopenia is related to poor prognosis in patients after trimodality therapy for locally advanced non-small cell lung cancer.1 passage
• Sarcopenia predicts survival outcomes among patients with urothelial carcinoma of the upper urinary tract undergoing radical nephroureterectomy: a retrospective multi-institution study.1 passage
• Sarcopenia, but not visceral fat amount, is a risk factor of postoperative complications after major hepatectomy.1 passage
• Screening rate for hepatitis B virus infection in patients undergoing chemotherapy in Japan.1 passage
• Second primary cancers: a retrospective analysis of real world data using the enhanced medical research engine ConSoRe in a French comprehensive cancer center.1 passage
• Second-line chemotherapy using taxane in patients with advanced gastric cancer who presented with severe peritoneal metastasis: a multicenter retrospective study.1 passage
• Secondary cancer after a childhood cancer diagnosis: viewpoints considering primary cancer.1 passage
• Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in Japan.1 passage
• Selecting patients for hyperthermia combined with preoperative chemoradiotherapy for locally advanced rectal cancer.1 passage
• Sentinel lymph node biopsy using indocyanine green fluorescence in early-stage breast cancer: a meta-analysis.1 passage
• Sequential chemotherapy using gemcitabine + carboplatin followed by gemcitabine + carboplatin + docetaxel for advanced upper-tract urothelial cancer.1 passage
• Serum LOX-1 is a novel prognostic biomarker of colorectal cancer.1 passage
• Serum iron levels increased by cancer chemotherapy correlate the chemotherapy-induced nausea and vomiting.1 passage
• Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer.1 passage
• Serum zinc deficiency in patients after gastrectomy for gastric cancer.1 passage
• Short hydration with 20 mEq of magnesium supplementation for lung cancer patients receiving cisplatin-based chemotherapy: a prospective study.1 passage
• Short-term low-volume hydration in cisplatin-based chemotherapy for patients with lung cancer: the second prospective feasibility study in the Okayama Lung Cancer Study Group Trial 1201.1 passage
• Signet ring cell component in pretreatment biopsy predicts pathological response to preoperative chemoradiotherapy in rectal cancer.1 passage
• Significance of D-dimer-based screening for detecting pre-operative venous thromboembolism in patients with esophageal cancer after neoadjuvant chemotherapy.1 passage
• Significance of RAS mutations in pulmonary metastases of patients with colorectal cancer.1 passage
• Significance of multiple preoperative laboratory abnormalities as prognostic indicators in patients with urothelial carcinoma of the upper urinary tract following radical nephroureterectomy.1 passage
• Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy.1 passage
• Significance of prostate-specific antigen kinetics after three-dimensional conformal radiotherapy with androgen deprivation therapy in patients with localized prostate cancer.1 passage
• Significance of re-biopsy of histological tumor samples in advanced non-small-cell lung cancer in clinical practice.1 passage
• Significance of sarcopenia as a prognostic factor for metastatic urothelial carcinoma patients treated with systemic chemotherapy.1 passage
• Significant impact of R.E.N.A.L. nephrometry score on changes in postoperative renal function early after robot-assisted partial nephrectomy.1 passage
• Simplified HCC-ART score for highly sensitive detection of small-sized and early-stage hepatocellular carcinoma in the widely used Okuda, CLIP, and BCLC staging systems.1 passage
• Single-cycle induction chemotherapy for resectable advanced hypopharyngeal cancer.1 passage
• Skeletal muscle loss during systemic chemotherapy for colorectal cancer indicates treatment response: a pooled analysis of a multicenter clinical trial (KSCC 1605-A).1 passage
• Skeletal-related events and prognosis in urothelial cancer patients with bone metastasis.1 passage
• Small-volume lymph node involvement and biochemical recurrence after robot-assisted radical prostatectomy with extended lymph node dissection in prostate cancer.1 passage
• Spectrum of cancer risk among Taiwanese with chronic obstructive pulmonary disease.1 passage
• Squamous cell carcinoma of the bladder: poor response to neoadjuvant chemotherapy.1 passage
• Statistical challenges for central monitoring in clinical trials: a review.1 passage
• Status of oncologic specialties: global survey of physicians treating cancer.1 passage
• Stereotactic body radiation therapy for primary lung cancers clinically diagnosed without pathological confirmation: a single-institution experience.1 passage
• Stereotactic body radiotherapy in patients with chronic obstructive pulmonary disease and interstitial pneumonia: a review.1 passage
• Strategies for dealing with fraud in clinical trials.1 passage
• Stromal markers AKR1C1 and AKR1C2 are prognostic factors in primary human breast cancer.1 passage
• Stromal tumor-infiltrating lymphocytes level as a prognostic factor for resected intrahepatic cholangiocarcinoma and its prediction by apparent diffusion coefficient.1 passage
• Suppressive effect upon carboplatin hypersensitivity reaction via pegylated liposomal doxorubicin combination therapy.1 passage
• Surgical margin clearance and extended chemotherapy defines survival for synchronous oligometastatic liver lesions of the ductal adenocarcinoma of the pancreas.1 passage
• Surgical outcome and graded prognostic assessment of patients with brain metastasis from adult sarcoma: multi-institutional retrospective study in Japan.1 passage
• Surgical outcome of patients with lung cancer involving the left atrium.1 passage
• Surgical outcomes of early-stage primary vaginal nonsquamous cell carcinoma.1 passage
• Surveillance of radical hysterectomy for early-stage cervical cancer in the early experienced period of minimally invasive surgery in Japan.1 passage
• Surveillance policy for Japanese patients with stage I testicular germ cell cancer in the multi-detector computed tomography era.1 passage
• Survey of the clinical practice pattern of using sentinel lymph node biopsy in patients with gynecological cancers in Japan: the Japan Society of Gynecologic Oncology study.1 passage
• Survival and chemotherapy-related risk of second primary malignancy in breast cancer patients: a SEER-based study.1 passage
• Survival benefit of adjuvant chemotherapy in elderly patients with colon cancer: a systematic review and meta-analysis.1 passage
• Survival impact of adjuvant concurrent chemoradiotherapy after radical hysterectomy in FIGO stage IIIC1 cervical adenocarcinoma.1 passage
• Survival impact of local extension sites in surgically treated patients with temporal bone squamous cell carcinoma.1 passage
• Survival outcomes following craniotomy for intracranial metastases from an unknown primary.1 passage
• Survival prediction and treatment strategies for patients with advanced laryngeal carcinoma: a population-based study.1 passage
• Survivin rs9904341 polymorphism significantly increased the risk of cancer: evidence from an updated meta-analysis of case-control studies.1 passage
• Swallowing dysfunction following surgery for well-differentiated thyroid cancer with extrathyroid invasion.1 passage
• Symptoms and signs of parotid tumors and their value for diagnosis and prognosis: a 20-year review at a single institution.1 passage
• Systematic study on expression and prognosis of E2Fs in human colorectal cancer.1 passage
• Systemic chemotherapy for gastric cancer with early recurrence after adjuvant S-1 monotherapy: a multicenter retrospective study.1 passage
• T-cell lymphomas, a challenging disease: types, treatments, and future.1 passage
• TERT promotor region rearrangements analyzed in high-risk neuroblastomas by FISH method and whole genome sequencing.1 passage
• TRIM37 overexpression is associated with chemoresistance in hepatocellular carcinoma via activating the AKT signaling pathway.1 passage
• Tandem high-dose chemotherapy with topotecan-thiotepa-carboplatin and melphalan-etoposide-carboplatin regimens for pediatric high-risk brain tumors.1 passage
• Targeting DNA repair and replication stress in the treatment of ovarian cancer.1 passage
• Targeting metabolic reprogramming in KRAS-driven cancers.1 passage
• Template-based lymphadenectomy reduces the risk of regional lymph node recurrence among patients with upper/middle ureteral cancer.1 passage
• Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation.1 passage
• Ten-year outcomes of intensity-modulated radiation therapy combined with neoadjuvant hormonal therapy for intermediate- and high-risk patients with T1c-T2N0M0 prostate cancer.1 passage
• Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan.1 passage
• The 5-year outcomes of moderately hypofractionated radiotherapy (66 Gy in 22 fractions, 3 fractions per week) for localized prostate cancer: a retrospective study.1 passage
• The DEAD-box protein family of RNA helicases: sentinels for a myriad of cellular functions with emerging roles in tumorigenesis.1 passage
• The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV.1 passage
• The MDM2 rs937283 A > G variant significantly increases the risk of lung and gastric cancer in Chinese population.1 passage
• The Real-World status and risk factors for a poor prognosis in elderly patients with primary central nervous system malignant lymphomas: a multicenter, retrospective cohort study of the Tohoku Brain Tumor Study Group.1 passage
• The cancer-related transcription factor Runx2 combined with osteopontin: a novel prognostic biomarker in resected osteosarcoma.1 passage
• The carcinoembryonic antigen ratio is a potential predictor of survival in recurrent colorectal cancer.1 passage
• The clinical features of squamous cell lung carcinoma with sensitive EGFR mutations.1 passage
• The clinical prognostic factors and treatment outcomes of adult patients with Ewing sarcoma.1 passage
• The clinical use of neutrophil-to-lymphocyte ratio in bladder cancer patients: a systematic review and meta-analysis.1 passage
• The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study.1 passage
• The concept and evolution of involved site radiation therapy for lymphoma.1 passage
• The correlation between plasma aprepitant concentration and antiemetic effect in Japanese gastric or esophageal cancer patients.1 passage
• The correlation of immunoscore and frailty in colorectal cancer.1 passage
• The cumulative incidence and risk factors of postoperative inguinal hernia in patients undergoing radical prostatectomy.1 passage
• The detection of sentinel lymph nodes in laparoscopic surgery can eliminate systemic lymphadenectomy for patients with early stage endometrial cancer.1 passage
• The development and external validation of a nomogram predicting overall survival of gastric cancer patients with inadequate lymph nodes based on an international database.1 passage
• The diagnostic role of the neutrophil-to-lymphocyte ratio in predicting pancreatic ductal adenocarcinoma in patients with pancreatic diseases.1 passage
• The effect of consolidation chemotherapy after concurrent chemoradiotherapy on the survival of patients with locally advanced non-small cell lung cancer: a meta-analysis.1 passage
• The effect of extensive intraoperative peritoneal lavage therapy (EIPL) on stage III B + C and cytology-positive gastric cancer patients.1 passage
• The effect of gefitinib in patients with postoperative recurrent non-small cell lung cancer harboring mutations of the epidermal growth factor receptor.1 passage
• The effectiveness of high-dose-rate brachytherapy with external beam radiotherapy for clinically locally advanced and node-positive prostate cancer: long-term results of a retrospective study.1 passage
• The effects of intraoperative ICG fluorescence angiography in laparoscopic low anterior resection: a propensity score-matched study.1 passage
• The efficacy and safety of Apatinib mesylate in the treatment of metastatic osteosarcoma patients who progressed after standard therapy and the VEGFR2 gene polymorphism analysis.1 passage
• The efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.1 passage
• The efficacy and safety profile of 2-weekly dosing of bevacizumab-containing chemotherapy for platinum-resistant recurrent ovarian cancer.1 passage
• The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia.1 passage
• The efficacy and toxicity of metronomic oral vinorelbine monotherapy in patients with non-small cell lung cancer: a meta-analysis.1 passage
• The efficacy of a third-generation oncolytic herpes simplex viral therapy for an HPV-related uterine cervical cancer model.1 passage
• The efficacy of adjuvant chemotherapy for resected high-risk stage II and stage III colorectal cancer in frail patients.1 passage
• The efficacy of aprepitant in salvage treatment of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy for patients with gastrointestinal cancer.1 passage
• The efficacy of radio-frequency ablation for metastatic lung or liver tumors of male germ cell tumors as an alternative minimally invasive therapy after salvage chemotherapy.1 passage
• The efficacy of surgical treatment of recurrent or persistent cervical cancer that develops in a previously irradiated field: a monoinstitutional experience.1 passage
• The evolution of surgical treatment for gastrointestinal cancers.1 passage
• The expression and clinical significance of the tRNA aspartic acid methyltransferase 1 protein in gastric cancer.1 passage
• The impact of a fourteen-gene molecular assay on physician treatment decisions in non-small-cell lung cancer.1 passage
• The impact of body mass index on oncological outcomes in colorectal cancer patients with curative intent.1 passage
• The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy.1 passage
• The impact of clinicopathological factors on clinical outcomes in patients with salivary gland adenoid cystic carcinoma: a multi-institutional analysis in Japan.1 passage
• The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study.1 passage
• The impact of postoperative inflammation on recurrence in patients with colorectal cancer.1 passage
• The impact of programmed cell death-ligand 1 (PD-L1) and CD8 expression in grade 3 endometrial carcinomas.1 passage
• The impact of sex and age on distribution of metastases in patients with renal cell carcinoma.1 passage
• The incidence of newly diagnosed secondary cancer; sub-analysis the prospective study of the second-look procedure for transoral surgery in patients with T1 and T2 head and neck cancer.1 passage
• The initial assessment of expert panel performance in core hospitals for cancer genomic medicine in Japan.1 passage
• The key role of calreticulin in immunomodulation induced by chemotherapeutic agents.1 passage
• The metabolic syndrome is associated with the risk of urothelial carcinoma from a health examination database.1 passage
• The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma.1 passage
• The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study.1 passage
• The neutrophil-to-lymphocyte ratio as a predictor of intravesical recurrence in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.1 passage
• The novel index using preoperative C-reactive protein and neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with pancreatic cancer.1 passage
• The post hoc analysis comparing the severity grades of chemoradiotherapy-induced oral mucositis scored between the central and local assessors in a multicenter, randomized controlled trial of rebamipide for head and neck cancer.1 passage
• The predictors and oncological outcomes of repeat surgery for recurrence after hepatectomy for colorectal liver metastases.1 passage
• The present state and perception of young women with breast cancer towards breast reconstructive surgery.1 passage
• The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer.1 passage
• The prevalence of secondary neoplasms in acromegalic patients: possible preventive and/or protective role of metformin.1 passage
• The processus vaginalis transection method is superior to the simple prophylactic procedure for prevention of inguinal hernia after radical prostatectomy.1 passage
• The prognosis of osteosarcoma occurring as second malignancy of childhood cancers may be favorable: experience of two cancer centers in Japan.1 passage
• The prognostic impact of immune-related adverse events in metastatic renal cell carcinoma patients treated with nivolumab: a real-world multi-institutional retrospective study.1 passage
• The prognostic role of prognostic nutritional index in nasopharyngeal carcinoma: A systematic review and meta-analysis.1 passage
• The prognostic significance of surgical treatment for excessive elderly patients with soft tissue sarcoma.1 passage
• The prognostic significance of whole-body and spleen MTV (metabolic tumor volume) scanning for patients with diffuse large B cell lymphoma.1 passage
• The prognostic value of routine second transurethral resection in patients with newly diagnosed stage pT1 non-muscle-invasive bladder cancer: results from randomized 10-year extension trial.1 passage
• The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy.1 passage
• The rate of facial nerve dysfunction and time to recovery after intraparotid and extraparotid facial nerve exposure and protection in head and neck cutaneous tumor surgery.1 passage
• The role of LINE-1 methylation in predicting survival among colorectal cancer patients: a meta-analysis.1 passage
• The role of additional hysterectomy after concurrent chemoradiation for patients with locally advanced cervical cancer.1 passage
• The role of lymph nodes in cervical cancer: incidence and identification of lymph node metastases-a literature review.1 passage
• The role of periodic serum CA19-9 test in surveillance after colorectal cancer surgery.1 passage
• The sesquiterpene α-bisabolol in the adipocyte-cancer desmoplastic crosstalk: does it have an action on epithelial-mesenchymal transition mechanisms?1 passage
• The significance of micro-lymphatic invasion and pathological Gleason score in prostate cancer patients with pathologically organ-confined disease and negative surgical margins after robot-assisted radical prostatectomy.1 passage
• The survival and prognosticators of peritoneal cytology-positive gastric cancer patients who received upfront gastrectomy and subsequent S-1 chemotherapy.1 passage
• The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score.1 passage
• The use of neoadjuvant therapy for resectable locally advanced thoracic esophageal squamous cell carcinoma in an analysis of 5016 patients from 305 designated cancer care hospitals in Japan.1 passage
• The usefulness of 18F-FDG-PET/CT in discriminating benign from malignant ovarian teratomas.1 passage
• The usefulness of microRNA in urine and saliva as a biomarker of gastroenterological cancer.1 passage
• The utility of ground-glass attenuation score for anticancer treatment-related acute exacerbation of interstitial lung disease among lung cancer patients with interstitial lung disease.1 passage
• The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.1 passage
• The value of circulating CYFRA21-1 expression in patients with nasopharyngeal carcinoma: a study of 529 subjects.1 passage
• The value of lymphadenectomy in surgical resection of perihilar cholangiocarcinoma: a systematic review and meta-analysis.1 passage
• Therapeutic drug monitoring of regorafenib and its metabolite M5 can predict treatment efficacy and the occurrence of skin toxicities.1 passage
• Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases.1 passage
• Thrombotic events induce the worse prognosis in ovarian carcinomas and frequently develop in ovarian clear cell carcinoma.1 passage
• Thymic carcinoma patients with myasthenia gravis exhibit better prognoses.1 passage
• Time to biochemical relapse after radical prostatectomy and efficacy of salvage radiotherapy in patients with prostate cancer.1 passage
• Timing and characteristics of radiation pneumonitis after stereotactic body radiotherapy for peripherally located stage I lung cancer.1 passage
• Tissue thioredoxin-interacting protein expression predicted recurrence in patients with meningiomas.1 passage
• To what extent does the EQ-5D-3L correlate with the FACT-H&N of patients with oral cancer during the perioperative period?1 passage
• Tolerability and safety of adjuvant chemoradiotherapy with S-1 after limited surgery for T1 or T2 lower rectal cancer.1 passage
• Total iron-binding capacity is a novel prognostic marker after curative gastrectomy for gastric cancer.1 passage
• Transoral robotic surgery in management of oropharyngeal cancers: a preliminary experience at a tertiary cancer centre in India.1 passage
• Treatment choices and outcomes of non-metastatic hepatocellular carcinoma patients in relationship to neighborhood socioeconomic status: a population-based study.1 passage
• Treatment intensity and control rates in combining external-beam radiotherapy and radioactive iodine therapy for metastatic or recurrent differentiated thyroid cancer.1 passage
• Treatment modalities for Māori and New Zealand European men with localised prostate cancer.1 passage
• Treatment outcome of laparoscopic surgery after self-expandable metallic stent insertion for obstructive colorectal cancer.1 passage
• Treatment outcomes of external-beam radiotherapy for squamous cell carcinoma of the base of the tongue.1 passage
• Treatment outcomes of hypofractionated radiotherapy combined with temozolomide followed by bevacizumab salvage therapy in glioblastoma patients aged > 75 years.1 passage
• Treatment outcomes of patients with spinal metastases derived from hepatocellular carcinoma.1 passage
• Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with salvage surgery after concurrent chemoradiotherapy.1 passage
• Treatment strategies for neuroendocrine carcinoma of the upper digestive tract.1 passage
• Treatment-associated outcomes of patients with primary ocular adnexal MALT lymphoma after accurate diagnosis.1 passage
• Trends in incidence and long-term survival of Japanese women with vulvar cancer: a population-based analysis.1 passage
• Trends in the cervical cancer screening rates in a city in Japan between the years of 2004 and 2013.1 passage
• Trim44 facilitates the migration and invasion of human lung cancer cells via the NF-κB signaling pathway.1 passage
• Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial).1 passage
• Triplet induction chemotherapy followed by less invasive surgery without reconstruction for human papillomavirus-associated oropharyngeal cancers: Why is it successful or unsuccessful?1 passage
• Tumor angiogenesis--characteristics of tumor endothelial cells.1 passage
• Tumor budding as a predictive marker for 5-fluorouracil response in adjuvant-treated stage III colorectal cancer.1 passage
• Tumor growth patterns on magnetic resonance imaging and treatment outcomes in patients with locally advanced cervical cancer treated with definitive radiotherapy.1 passage
• Tumor hypoxia: a new PET imaging biomarker in clinical oncology.1 passage
• Type C2 radical hysterectomy may improve outcomes of locally advanced mucinous adenocarcinoma of the uterine cervix.1 passage
• Type of second primary malignancy after achieving complete response by definitive chemoradiation therapy in patients with esophageal squamous cell carcinoma.1 passage
• UDP-glucuronosyltransferase 1A1*6 and *28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer.1 passage
• Ultrasound-based logistic regression model LR2 versus magnetic resonance imaging for discriminating between benign and malignant adnexal masses: a prospective study.1 passage
• Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure.1 passage
• Urinalysis by combination of the dipstick test and urine protein-creatinine ratio (UPCR) assessment can prevent unnecessary lenvatinib interruption in patients with thyroid cancer.1 passage
• UroVysion1 passage
• Use of a prognostic risk score that aggregates the FDG-PET/CT SUVmax, tumor size, and histologic group for predicting the prognosis of pStage I lung adenocarcinoma.1 passage
• Use of direct oral anti-coagulants for the treatment of venous thromboembolism in patients with advanced cancer: a prospective observational study.1 passage
• Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥ 75 years after radical cystectomy for treatment of bladder cancer.1 passage
• Use of warm Ringer's lactate solution in the management of locally advanced giant cell tumor of bone.1 passage
• Usefulness of alternate-day administration of S-1 and leucovorin in a xenograft mouse model of colorectal cancer: a shorter drug-free interval leads to more efficient antitumor effects.1 passage
• Usefulness of cell-free and concentrated ascites reinfusion therapy in the therapeutic management of advanced ovarian cancer patients with massive ascites.1 passage
• Usefulness of fluorescence visualization-guided surgery for early-stage tongue squamous cell carcinoma compared to iodine vital staining.1 passage
• Utility of whole brain radiation therapy for leptomeningeal carcinomatosis.1 passage
• Validation of prognostic impact of number of extrathoracic metastases according to the eighth TNM classification: a single-institution retrospective study in Japan.1 passage
• Validation of the 8th edition of the AJCC/UICC TNM staging system for tongue squamous cell carcinoma.1 passage
• Validation of the risk factors for primary control of early T-stage laryngeal, oropharyngeal, and hypopharyngeal squamous cell carcinoma by transoral surgery: a prospective observational study.1 passage
• Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary.1 passage
• Values of alkaline phosphatase at the diagnosis of castration resistance and response to primary androgen deprivation therapy as predictors of subsequent metastasis in non-metastatic castration-resistant prostate cancer.1 passage
• Variant of SNPs at lncRNA NEAT1 contributes to gastric cancer susceptibility in Chinese Han population.1 passage
• Variations in clinical features and oncologic behaviors of T1 colorectal cancer according to tumor location.1 passage
• Verification of the diagnostic strategy for anterior mediastinal tumors.1 passage
• Visceral-to-subcutaneous fat ratio is a possible prognostic factor for type 1 endometrial cancer.1 passage
• Volumetric and texture analysis on FDG PET in evaluating and predicting treatment response and recurrence after chemotherapy in follicular lymphoma.1 passage
• Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II study.1 passage
• Why is renal impairment associated with poorer cancer specific survival in breast cancer patients?: a comparison with patients with other comorbidities.1 passage
• YAP promotes self-renewal of gastric cancer cells by inhibiting expression of L-PTGDS and PTGDR2.1 passage
• [18F]fluoro-2-deoxyglucose-positron emission tomography for the assessment of histopathological response after preoperative chemoradiotherapy in advanced oral squamous cell carcinoma.1 passage
• c-D-index is a risk factor for prolonged febrile neutropenia during chemotherapy in patients with acute myeloid leukemia.1 passage
• mFOLFOX6 plus bevacizumab to treat liver-only metastases of colorectal cancer that are unsuitable for upfront resection (TRICC0808): a multicenter phase II trial comprising the final analysis for survival.1 passage